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ABSTRACT 
 
The immune system is composed of an innate and an adaptive response that protects us from 
the microbial attacks. The innate system provides a fast defense against infection. However, 
many microbes evade or overwhelm the innate host defenses and establish the infection in the 
host. In these cases, the innate immune system will be determinant in triggering the adaptive 
immune responses. The adaptive immunity consists of antibody-mediated immunity, and T 
cell-mediated immunity. T cells are the central object of study in this thesis.  
The thymus is a specialized primary lymphoid organ for T cell development from 
hematopoietic stem cells. Histologically, thymus can be divided into two parts, the central 
medulla and the peripheral cortex. Cells in thymus consist of developing T cells termed 
thymocytes and stromal cells including cortical epithelial cells (cTEC), medullary epithelial 
cells (mTEC), as well as dendritic cells (DC). The crosstalk between thymocytes, TECs and 
DCs that occurs via cell-to-cell contact, cytokines and growth factors is critical for T cell 
development.  
Several cytokines and growth factors activate the JAK/ STATs signaling pathway after 
binding to their specific receptors. The activated STATs transcription factors will later 
translocate to the nucleus and initiate the transcription of a variety of genes.  The “Suppressor 
of Cytokine Signaling” (SOCS) is a family of proteins including SOCS1-7 and CISH that 
hamper the activation of different STAT transcription factors. STAT3 has been shown to be 
critical for the differentiation of many immune cells including those of different T helper 
subsets.  STAT3 is involved in both inflammatory and anti-inflammatory responses.  SOCS3 
is a negative regulator of STAT3 when activated by some (but not all) cytokines. The role of 
SOCS3 in T cell development in the thymus is unknown. 
The purpose of this thesis is to study the role of SOCS3 in T cell development in thymus. The 
role of SOCS3, CISH and STAT3 in control of M.tuberculosis infection was also addressed. 
By using an inducible SOCS3 conditional knockout mouse model, we demonstrated that 
SOCS3 was required for T cell development. The thymus from mice with SOCS3 deletion 
was atrophied, with a 90% decrease of thymus cellularity, and a high frequency of apoptosis 
on double positive (DP) thymocytes and a reduced differentiation of DN thymocytes to single 
positive (SP) cells. Experiments with bone marrow radiation chimeras indicated that SOCS3 
in thymic stromal cells was involved in the T cells development. In addition, hematoxylin and 
eosin (HE) and immunohistochemistry staining showed that the mice with SOCS3 deletion 
displayed a thymus with disorganized cortex and medulla. However, SOCS3 did not alter the 
number of TEC but was necessary for the TEC maturation. A transcriptome analysis of TECs 
indicated that genes involved in apoptosis and cell survival, negative selection and lympho-
stromal interactions were regulated by SOCS3. 
  
Tuberculosis (TB) caused by infection with Mycobacterium tuberculosis is one of the top 10 
causes of death worldwide. Approximately 90–95% of infected individuals successfully 
contain M. tuberculosis but 5–10% infected individuals will develop active TB. The 
mechanisms behind reactivation are still not well understood. SOCS3 in myeloid cells was 
shown to be critical for the control of infection with Mycobacterium tuberculosis. Moreover, 
single nucleotide polymorphisms (SNPs) of cish gene were associated with an increased risk 
of TB. 
Here we found mice deficient in STAT3 in myeloid cells had a decreased susceptibility to 
M.tuberculosis, with lower bacteria load in lungs and spleen, higher level of neutrophils 
infiltration and less area occupied by granuloma in lung. In STAT3 deficient mice, the levels 
of il-6, il-23, il-17 and il22 mRNA in lungs were increased during infection. STAT3 deficient 
bone marrow derived macrophages or dendritic cells expressed high levels of IL-6 and IL-23 
at the protein and mRNA after M. tuberculosis infection. Furthermore, antigen-specific T 
cells released higher levels of IL-17 when co-cultured with M. tuberculosis infected APCs 
with STAT3 deficiency, indicating that STAT3 in APCs hampered Th17 differentiation and 
IL-17 secretion. The increased IL-17 levels resulted in an improved control of infection 
because neutralization of IL-17 receptor A in STAT3 deficient mice hampered bacterial 
control, as well as the neutrophil infiltration. Mice deficient in SOCS3 in myeloid cells or 
DCs were more susceptible to M. tuberculosis infection. The secretion of IL-17 by 
mycobacteria specific T cells was reduced when these cells were stimulated by mycobacteria- 
infected SOCS3 deficient APCs.  
Additionally, we showed that the SOCS family member CISH was induced during 
M.tuberculosis infection. We found that cish
-/-
 mice had higher bacteria load in spleens and 
lungs up to 2.5 weeks after infection but not later compared to controls. This was associated 
to a decreased expression of transcripts of inos and tnf, which mediate defense against 
M.tuberculosis early but not late after infection. In addition, rag1
-/-
 mice adaptively 
transferred with cish
-/-
 or control T cells displayed similar protection to infection with 
M.tuberculosis. 
In conclusion, we demonstrated that SOCS3 expression in non-hematopoietic cells played a 
critical role for T cell development in the thymus and for maintenance of thymus architecture. 
On the other hand, STAT3 expression in myeloid cell hampers the control of M.tuberculosis 
infection by hampering Th17 stimulating cytokines secretion and the secretion of IL-17 by 
CD4+ T cells. In addition, we showed that CISH-mediated the control of M. tuberculosis in 
mice at an early stage of infection by the regulation of the innate immune responses. 
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1 INTRODUCTION 
 
The immune system is a host defense system composed of a series of biological 
structures and processes within organism, which can detect many pathogens and 
harmful substances such as bacteria, virus, fungus and parasite and distinguish them 
from body's own healthy cells and tissues. The immune system is an interactive 
network consists with lymphoid tissues, immune cells, cytokines and humoral factors 
[1].  
The immune system is classified into innate immune system and adaptive immune 
system according to the speed and specificity of the immune responses. The innate 
immune system including physical (skin, mucosa, epithelium), chemical (antimicrobial 
peptides, enzymes), and biological barriers, consists of a variety of immune elements 
such as inflammation, complement system mediated cascade events, neutrophils, 
monocytes, macrophages, dendritic cells, natural killer cells, γδ T cells, and different 
kinds of cytokines[2, 3].  
Although the innate immune system can effectively prevent the penetration of 
pathogens into the body, some of them successfully evolved to escape the innate 
immune responses and thereby trigger the adaptive immune response. This response 
is composed of T lymphoctyes- and B lymphocytes-mediated antigen-specific 
reactions. The hallmark of adaptive immunity is to provide a stronger immune 
response and immune memory so that each pathogen can be "remembered" by the 
immune system through specific epitopes. The specificity of adaptive immunity is the 
recognition of "non-self" antigens by antigen-specific receptors on T and B cells 
interacting with major histocompatibility complex (MHC) molecules via a process 
called antigen presentation[4, 5]. 
1.1 T cell development in thymus 
T cells differentiate from hematopoietic stem cells localized in the bone marrow (BM). 
Unlike other hematologic cell lineages, T cell development occurs in the thymus, which 
provides an inductive environment for maturation of T cell progenitors and for 
commitment to different T cell lineages. The TCR rearrangement, and the 
positive/negative selections occur in the thymus [6, 7]. The earliest T cell progenitors, 
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the double negative (DN) cells lack expression of both CD4 and CD8 co-receptors.  
Depending on the differential expression of CD25, CD44 and CD117 receptors, the DN 
stage is further subdivided into four stages (DN1 through DN4)[8]. After the DN stage 
T cells will differentiate into DP (double positive cells) expressing both CD4 and CD8.  
1.1.1 DN1 Cells 
Thymus-settling progenitors (TSPs) comprise a heterogeneous mixture of multipotent 
progenitors (MPPs), common lymphoid progenitors (CLPs), CLP-like cells and T 
lineage-committed progenitors. The process of TSPs passing through postcapillary 
venules at the corticomedullary junction (CMJ) to enter the thymus is mediated by 
CCR7/CCR9 binding chemokines. The TSPs differentiate into early T lineage 
progenitors (ETPs) that migrate to the outer part of the cortex, before they progress 
through the different DN stages [9-12]. Differentiation to the DN1 stage 
(CD25−CD44high) occurs around the area of thymic entry. However, DN1 cells still 
keep the potential to differentiate to non-T lineages such as DCs, macrophages (MØ) 
and NK cells. Specific signaling pathways thus are required to restrict this potential 
and guide the T lineage commitment. Several studies have described that Notch 
signaling is required for the generation and differentiation of ETPs [13-17]. In 
addition, IL-7R and CD117 (the stem cell factor receptor) are crucial for the 
proliferative expansion of early pro-T cells and DN1 cells within the thymus [18, 19].  
1.1.2 DN2 cells 
DN2 thymocytes with CD25+ CD44+ CD117+ phenotype are developed from DN1 cells 
when they migrate from the CMJ toward the subcapsular area of the cortex, where 
they interact with cortical thymic epithelial cells (cTECs) and fibroblasts [20, 21]. The 
hallmarks for DN2 stage are the further restricted T-lineage commitment, and the 
initiation of gene rearrangement at the TCRγ, TCRδ, and TCRβ gene loci [22]. Based on 
the CD117 expression level, DN2 cells are divided into two subsets, DN2a 
(CD25+CD44+CD117high) and DN2b (CD25+CD44+CD117int) [23]. By using the 
eGFP/lck cre transgenic mouse model, Masuda et al. found that DN2a cells still 
maintain the potential to differentiate to DCs and NK cells, whereas DN2b subset can 
only develop to NK cells [24]. Later, a study by Li et al. demonstrated that the 
expression of zinc finger transcription factor Bcl11b could repress the NK cell 
differentiation potential on DN2b subset and determine T lineage commitment [25]. 
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Similarly, according to the expression level of IL-7R, DN2 cells have been divided into 
two subpopulations, IL-7Rαhigh and IL-7Rαlow, which are biased for the γδ and αβ T cell 
lineages, respectively [26]. However, several signaling pathways for T-lineage (γδ/αβ 
T cell) choice have been investigated, such as extracellular signal regulated kinase 
(ERK)- early growth response (Egr)- inhibitor of differentiation 3 (Id3) axis, with 
strong signal guiding the γδ and weak signal guiding the αβ T lineage commitment 
[27]. Not only T cell lineage commitment, but also the further development of 
thymocytes from early phases to up to the DN3 stage requires Notch signal. Notch 
signaling in all the early stages of T cell development dampers other lineage 
potentials, such as B lymphocyte and myeloid cell differentiation[28]. IL-7/IL-7R 
signaling pathway is required for the survival of DN cells during early T-cell 
development[29]. IL-7 expressed by TECs binds to IL-7R to activate the Jak1 and 
JAK3/STAT5 signaling pathway, triggering the downstream gene Bcl-2 expression, 
which prolongs the survival of TCRβ+ cells (DN2 to DN3a). Moreover, the activation of 
transcription factor nuclear factor of activated T-cells (NFAT) c1 mediated by IL-
7/JAK3/P-Tyr371 shown in DN2 and DN3 cells was reported to be the alternative way 
to trigger Bcl-2 anti-apoptosis signaling pathway[30]. 
1.1.3 DN3 cells 
Within the subcapsular zone of cortex, DN2 cells differentiate into DN3 that shows 
CD25+ CD44low expression. The DN3 stage is marked by the rearrangement TCRβ, 
TCRδ and TCRγ [18]. According to the different events progression on this DN3 stage, 
DN3 cells are divided into two parts: DN3a and DN3b. DN3a cells are continually 
progressing on TCR rearrangement and completing the αβ and γδ T cells fate 
specification. Successful recombination of γδ TCR and αβ T cell fate specification will 
occur at DN3a stage[31]. On the other hand, an important checkpoint termed β-
selection for αβ T cells development is ongoing during this phase. At this stage, DN3 
cells that successfully complete the βTCR rearrangement and assemble with an 
invariant pre-Tα and a CD3 chain to generate the functional pre-TCR will be allowed 
to progress; otherwise they are eliminated by apoptosis[32, 33]. The assembly of the 
pre-TCR complex initiates the rapid cell proliferation, as well as the termination of 
CD25 expression and enter the DN3b stage [18]. A number of signaling pathways 
involved in DN3 stage have been investigated in many studies. In DN3a stage, IL-7R 
and PI3K/Akt axis have been demonstrated to be involved in cell survival and 
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metabolism [34, 35]. Furthermore, a study performed by Trampont et al. showed that 
CXCR4/CXCL12 could regulate the localization and promote the survival and 
proliferation of immature thymocytes, and they concluded that CXCR4 was a co-
stimulator of the pre-TCR during β-selection [36]. 
1.1.4 DN4 and double positive (DP) cells 
After the DN3 stage, thymocytes progress to the DN4 stage with the extinction of CD25 
and CD44 expression. The DN4 cells migrate from subcapsular zone of cortex towards 
the medulla region. Following the pre-TCR formation and β-selection, DN4 cells 
initiate the expression of CD4 and CD8 and become DP cells. In this stage, thymocytes 
will re-express the RAG molecules to initiate the TCRα recombination [6, 19]. The 
immature DP thymocytes expressing T cell receptors that bind self-peptide–MHC 
complexes, which are presented by cTECs, will be positively selected. Depending on 
the MHC (I or II) that is presenting, they will commit to either CD4 or CD8 single 
positive (SP) cells. More than 90% of DP thymocytes die by neglect because of their 
useless TCRs [37].  
1.1.5 CD4+ and CD8+ SP cells 
SP cells migrate into the medulla region for the negative selection following the 
positive selection. During this selection, SP thymocytes carrying high-affinity TCRs 
that recognize tissue-restricted antigens (TRAs) presented by medullary epithelial 
cells (mTECs) and DCs would be eliminated. These cells otherwise will react with self 
antigens and generate autoimmune diseases[38]. The details of the positive and 
negative selection in the thymus are discussed below in the chapter of thymic 
epithelial cells.  
Finally, the up-regulation of sphingosine-1-phosphate receptor 1 (S1P1) on SPs will 
allow them to egress from the thymus into the circulation [39], as shown in figure 1. 
The receptor acts as a chemotactic receptor following gradient concentrations of S1P 
between thymus and the blood[40]. 
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Fig 1: T cell development in thymus 
 
1.1.6 Thymic epithelial cells 
The interaction between developing αβ T cells and thymic antigen-presenting cells 
with self-peptide embedded in MHC molecules is a critical checkpoint for T cell 
development, during positive and negative selection. Positive selection, mediated by 
cTECs, provides survival signaling to DP thymocytes and completes the commitment 
from DP cells to either the CD4+ or the CD8+ T cell lineage. Instead, negative selection 
mediated by mTECs and DCs results in central tolerance by clonal deletion. It also 
mediates nTreg cell selection and differentiation [41]. As a consequence of the 
positive and negative selection, a functional and self-tolerant αβ T cell repertoire is 
built up. The cTECs and mTECs have been shown to be differentiated from common 
bipotent thymic epithelial cell progenitors (bTECp) [42-44]. The bTECp are 
characterized by the expression of EpCAM1, Mts20 and Mts24 in embryonal thymus 
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[43, 45, 46]. A large number of molecules and transcription factors are required for 
TECs development and differentiation[47]. Jenkinson et al. showed that fibroblast 
growth factor (FGF) 7 and 10 expressed by thymus mesenchymal cells are necessary 
to support the proliferation of bTECp and lead to thymus growth [48]. The 
transcription factor forkhead box protein N1 (FOXN1) has been described as a critical 
regulator for TECs development in both the prenatal and the postnatal thymus[49]. 
FOXN1 regulates the activation of many genes [47]. By using chromatin 
immunoprecipitation sequencing (ChIP-seq) analysis, Žuklys and co-authors mapped 
FOXN1 target genes in postnatal TECs and identified a FOXN1 binding motif [50].  
1.1.6.1 cTECs development and positive selection 
The molecular mechanisms regulating cTECs differentiation are not completely 
understood. Surface molecules and transcription factors have been reported to 
identify the cTECs lineages. A murine study from Saba Shakib et al. showed that 
transcription factor FOXN1 initiated the development of cTECs from bTECp by up-
regulating the expression of CD205 as well as the co-stimulatory molecule CD40. 
Levels of CD40, MHC II, CD205 and the delta like ligand 4 (DLL4), which binds to 
Notch1, could be used to identify different stages of cTECs development[51-53]. 
Functional cTECs will present self-antigens to immature DP cells to mediate the 
positive selection. Antigen processing in cTECs has been discussed in many studies. 
For MHC class I antigen presentation, two murine studies performed by Murata et al. 
and Florea et al. showed that cTECs express a chymotrypsin-like activity proteasome 
subunit termed β5t, which is a key factor required for the generation of the MHC class 
I peptide repertoire involved in positive T cell selection[54, 55]. In addition, Nitta et al. 
found that the generation of CD8+ T cells in the absence of β5t is reduced in spleens 
and lymph nodes obviously, with defective allogeneic and antiviral responses[56].  
With regards to the MHC II antigen presentation, it seems to be mostly mediated by an 
unconventional pathway called macroautophagy, a process in which the cytoplasmic 
molecules are phagocytized into a double-membrane-limited organelle. The 
autophagosome fuses with endosomal and lysosomal vesicles resulting in degradation 
of the engulfed cytoplasmic proteins [57]. Interestingly, Nedjic et al. found that both 
cTECs and mTECs exhibited constitutive macroautophagy mediating the MHC II-
restricted antigen processing and presentation for both positive and negative 
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selection[58]. Two proteases, cathepsin L1 and thymus-specific serine protease 
(TSSP) expressed by cTECs, have been shown to be involved in MHC II antigen 
processing.  By using OT-II mice, a transgenic mouse model expressing MHC II-
restricted TCR, Gommeaux et al. found that the CD4 T cells positive selection was 
clearly impaired in the absence of TSSP, whereas CD8 T cells selection was not 
affected in OT-I mouse model[59, 60].  
1.1.6.2 mTECs development, negative selection and nTreg differentiation 
Recently positive selected CD4 or CD8 SP thymocytes have to move to the medulla, 
where they interact with mTECs, which express a wide spectrum of self-peptides 
derived from TRAs. The mTECs present self antigens to SP thymocytes and signal 
those CD4 or CD8 SP cells with high-affinity αβTCR binding to self-peptide-MHC 
complex to die via apoptosis and thereby delete from the T cell repertoire and create 
the central tolerance, which is termed negative selection[61]. Most of the TRAs 
expression is regulated by AIRE, a critical transcriptional regulator in terminal 
differentiated mTECs. AIRE dependent or independent TRAs expression is highly 
based on epigenetic mechanisms (histone modification and CpG methylation), which 
is well reviewed by Abramson[62]. 
The factors and molecular mechanisms involved in mTECs development have been 
extensively studied. Thymocyte-TEC interactions by RANK/RANKL, CD40/CD40L, 
lymphotoxin (LT) α/β resulting NFκB activation are critical for mTECs 
differentiation[63].  RANK and CD40 are critical for the AIRE+ and UEA+ mTECs 
differentiation [64]. A study by Akiyama et al. showed that the number of UEA+ and 
Aire+ mTECs were severely reduced in RANK deficient embryonic thymus. They could 
also see that RANK and CD40 were involved in the development and maintenance of 
mTECs in the postnatal thymus [65, 66].  
The role of the LT signaling pathway in mTECs development has been investigated in 
many studies by using LT receptor gene knockout mouse model. A study from Chin 
and colleagues claimed that LT signaling pathway is necessary for the expression of 
AIRE and its downstream target genes. They found that mice deficient in LTα or LTβR 
expressed lower level of AIRE and of several self-antigens in mTECs and consequently 
resulted in an impaired central tolerance[67]. Furthermore, by using the LTβ or LTβR 
deficient mouse model, Boehm et al. reported an impaired thymocytes-mTECs 
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crosstalk in the absence of LTβ /LTβR/ NFκB-inducing kinase (NIK) axis leading to a 
reduced number of mTECs and a disorganized medulla area, accompanied with the 
signs of autoimmunity[68]. In addition, LTβ/LTβR signaling is necessary for the 
expression of chemokines CCL21 and CCL19, which mediate CCR7+ SP cells migration 
toward the medulla for negative selection [69]. 
Unlike antigen presentation by cTECs, TRAs expressed by mTECs can be presented to 
T cells either by mTECs themselves or by neighboring DCs. During MHC I antigen 
processing, peptides are generated by two proteasome subunits β5 and β5i expressed 
in mTECs[37]. For MHC II-restricted self-antigens processing, similar to cTECs, mTECs 
generate self-antigens via macroautophagy and present them to CD4+ T cells [58]. In 
addition, antigen transfer between mTECs and DCs represents an additional pathway 
for negative selection. Unlike the cortex, the thymic medulla is packed with bone 
marrow (BM)–derived APCs[70]. Taniguchi et al. found that mice with MHC II 
deficient bone marrow derived cells displayed a higher frequency of auto-reactive 
CD4+ T cells [71].  
1.1.6.3 nTregs and mTECs 
Lei and co-authors showed that mTECs could express the chemokine XCL1 to recruit 
XCR1 expressing CD11c+ thymic DCs. By using the xcl1 deficient mice, they found that 
CD11c+ thymic DCs recruited by AIRE+ mTECs played a minor role in negative 
selection but were required for nTreg differentiation, which is a critical subpopulation 
preventing autoimmune diseases [72]. nTregs are generated at the same time as 
conventional αβ T cells during the negative selection. Unlike conventional CD4+ T 
cells, nTreg cells have a TCR repertoire that is primarily auto-reactive [73]. CD25- 
Foxp3+ CD4 SP cells or CD25+Foxp3- CD4 SP cells have been described as the 
precursors of nTregs. Additionally, IL-2 and IL-15 are necessary for the nTregs 
development in the thymus[74, 75].  
A study by Coquet and co-authors found that mTECs and CD8α+ conventional DCs in 
the thymic medulla performed CD27–CD70 co-stimulation to rescue developing Treg 
cells from apoptosis, subsequently inducing Foxp3 expression by TCR and CD28 
signals[76]. In addition, Mahmud et al. reported that UEA+ mTECs with constitutive 
expression of GITRL, OX40L and TNF could promote the differentiation of Tregs from 
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Tregs progenitors that express tumor-necrosis factor (TNF) receptor superfamily 
(TNFRSF) including GITR, OX40 and TNFR2[77]. 
1.2 Basics of STAT and SOCS  
Cytokines are a category of small proteins or peptides that are critical for cell 
signaling. Cytokines are mostly water-soluble proteins or glycoproteins with small 
molecular weight around 5 to 30 kDa[78].  
According to the structural homology, cytokines can be divided into four types: A 
family of cell molecules with four α-helical bundles. The family is divided into three 
subfamilies including Interleukin-2 (IL-2) subfamily, Interferon subfamily and IL-10 
subfamily; IL-1 cell molecular family mainly including IL-1 and IL-18; IL-17 cell 
molecular family and chemokines[79, 80]. Based on clinical and experimental 
functions, some of the cytokines are divided into: Type I helper T cell (Th1) cytokines, 
such as IFN-γ and TNF-α[81]; Type II helper T cell (Th2) cytokines such as IL-4, IL-13, 
IL-10, and transforming growth factor beta (TGF-β) [82]. These two types of cytokines 
tend to inhibit each other.  
Many different kinds of cell types, including immune cells like B lymphocytes, T 
lymphocytes, macrophages, dendritic cells, neutrophils, natural killer cells and mast 
cells, endothelial cells, epithelial cells and fibroblasts could produce cytokines.  
Cytokines therefore are involved in immune responses against inflammation, 
infectious and auto-immune diseases, as well as embryonic development[83]. 
Depending on their two features including the widespread distribution of cellular 
sources and redundancy, cytokines can be differed from another critical cell signaling 
molecules, hormones. Hormones circulate in less variable concentration and tend to 
be released by specific kinds of cells[84].  
The mode of cytokine action can be summarized as follows: autocrine, which means 
that cytokines act on the cells that release it; paracrine, which means that cytokines 
act on the cells around them and endocrine, which means cytokines spread to distant 
areas through circulation to influence different tissues[85].  
To initiate the biological functions, cytokines bind to specific receptors on the cell 
surface that mediate their signal transduction. Janus kinases–signal transducers and 
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activators of transcription (JAK–STAT) signaling pathway is the widely used a large 
number of cytokines as well as growth factors and hormones.  
1.2.1 STATs 
The JAK-STAT signaling pathway is involved in signal transduction of many cytokines, 
growth factors, and hormones during many cellular processes [86]. The family of 
STAT proteins with seven components comprises a unique class of transcription 
factors with a length between 750 and 850 amino acids that are characterized by the 
presence of four functional parts as follows (Figure 2): 1, the Src homology 2 (SH2) 
domain, which specifically recognizes the phosphorylated state of tyrosine residues at 
the cytokine receptors; 2, a C-terminal transactivation site, which includes tyrosine 
phosphorylation sites; 3, the amino acids between residues 400 and 500 of STAT 
proteins that constitute the DNA-binding site; 4, a coiled structure that presents a 
predominantly hydrophilic surface area for interaction with other proteins [87].  
 
Figure 2: Structure and function domains for STATs 
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Different cytokines that mediate their signaling via JAK/STATs signaling pathway are 
shown in Table 1. Interestingly, the use of the same type of STAT may render 
different biological consequences. 
STATs Activated by                                                                   Reference 
STAT1 IFN-α, β, γ                                                                         [88, 89] 
STAT2 IFN-α, β                                                                             [90, 91] 
STAT3 IL-6 family (IL-6, IL-11, IL-31, LIF, CNTF, CLC/CLF, NP, CT1, OSM), G-CSF, IL-10 
family (IL-10, IL-19, IL-20, IL-22, IL-24, IL-26), IL-21, IL-27, Leptin                             
[92, 93] 
STAT4 IL-12, 23[92, 94] 
STAT5A IL-2 family (IL-2, IL-4, IL-7, IL-9 and IL-15)          [95] 
STAT5B IL-2 family (IL-2, IL-4, IL-7, IL-9 and IL-15)          [95] 
STAT6 IL-4 and IL-13                                                                 [96] 
Table 1: Factors for STATs activation 
The JAK-STAT system consists of three main components: 1. the cytokine  receptor, 2. 
JAK kinases TYK2, JAK1, JAK2, JAK3 and 3. the STAT proteins [97]. Cytokines binding 
to their respective receptor induce a receptor aggregation. JAKs constitutively bind 
specific chains of these receptors and the aggregation results in JAK juxtaposition and 
their activation via cross-phosphorylation [98].  JAKs also phosphorylate the STAT 
proteins. STATs bind to the tyrosine-phosphorylated cytokine receptors through their 
SH2 domains and become phosphorylated on their C-terminal tyrosine residues (p-
Tyr or p-Ser) by the JAKs. Then phosphorylated STATs will dissociate from the 
receptor and mediate their dimerization. Different STATs form hetero- or 
homodimers. STAT dimers enter the nucleus, where they bind to specific DNA 
sequences in the promoter region of their target genes, and thus regulate their 
transcription [86]. The excessive stimulation mediated by cytokine-induced 
JAK/STATs signaling has been linked to several immune diseases [99]. For example, 
multiple sclerosis is due to the dysregulation of STAT1, STAT3 and STAT4 activation, 
which mediates the focal inflammatory infiltration into the central nervous system, 
demyelinating lesions, and pro-inflammatory cytokines production that activate 
immune cells and damage neurons and oligodendrocytes[100]. Thus, a tight control is 
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necessary to avoid the detrimental consequences of a pathogenic over stimulation. It 
has become clear that phosphotyrosine phosphatases (PTPs), protein inhibitors of 
activated STAT (PIAS), and suppressor of cytokine signaling (SOCS) proteins are the 
three classic inhibitory molecular families that contribute to the negative regulation of 
JAK/ STAT-mediated cytokine signaling [101].  
1.2.2 SOCS 
SOCS proteins are major regulators of JAK-STAT signaling but they control only some 
of the cytokines that activate JAK/STAT. SOCS proteins have been shown to widely 
regulate over 30 cytokines, including Leukemia Inhibitory Factor (LIF), Granulocyte 
Colony Stimulating Factor (G-CSF), Interferon-γ (IFN- γ), Interleukin-6 (IL-6) and IL-
10 [102]. The SOCS protein family consists of eight proteins, including SOCS1-7 and 
CIS [103]. All SOCS bind to different cytokine receptors. All eight proteins share a 
similar architecture that includes two functional domains: 1, a central SH2 domain, 
which binds to defined tyrosine-phosphorylated substrates on the cytokine receptor; 
and 2, a SOCS-box domain at their C-terminus, which binds elongins B and C and cullin 
5, thereby leading to the ubiquitination and degradation of its bound receptor [104-
106], as shown in Figure 3. In addition, the two most well known members of the 
SOCS family, SOCS1 and SOCS3, act through an additional mechanism: they use a short 
motif, named the kinase-inhibitory region (KIR) absent in the other members, to 
inhibit signaling by directly inhibiting the catalytic activity of JAKs [107, 108]. The 
suppressor of cytokine signaling-3 (SOCS3) protein is well known as a feedback 
inhibitor of the JAK/STAT3 pathway through binding to the shared interleukin-6 (IL-
6) receptor subunit gp130 inhibiting STAT3 phosphorylation [109].  
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Figure 3: Names and structures of SOCS family 
 
1.3 STAT3 and SOCS3 
STAT3 is a critical transcription factor that transmits signals to the nucleus after the 
activation by cytokine, growth factors and other stimuli [110]. STAT3 consists of six 
components: a C-terminal domain for transactivation, an SH2 domain for 
dimerization, a coiled-coil domain for protein-protein interactions, a linker region, a 
DNA-binding domain, and N-terminal domain (NTD)[111]. Based on the components, 
the signaling pathways for STAT3 activation have been investigated in many studies. 
STAT3 could be activated by tyrosine phosphorylation (P-Tyr705) via Janus kinases 
(JAKs), which leads to the P-STAT3 dimer formation through reciprocal 
phosphotyrosine-SH2 domain interactions. The dimer will translocate to nucleus and 
bind to specific DNA elements, consequently inducing gene expression. Meanwhile, 
serine phosphorylation (P-Ser727) at a site within the transactivation domain is 
another way for STAT3 activation, which is mediated by several serine kinases such as 
ERK1, ERK2, p38 and JNK[112, 113]. A plenty of studies have reported that STAT3 
within different tissues and cell types is involved in a broad variety of biological 
events, including acute-phase response induced by IL-6 in the liver, embryogenesis, 
cell growth and differentiation, pro-inflammatory and anti-inflammatory responses, 
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hematopoiesis, and tumor survival[110]. Excessive JAKs-STATs activation could 
mediate a detrimental effect on the organism, so that tight regulation by inhibitory 
molecules is necessary for the balance. JAKs-STATs pathways are controlled through 
several different mechanisms, including phosphotyrosine phosphatases (PTPs), 
protein inhibitor of activated STAT (PIAS) and SOCS proteins[114]. 
One function of SOCS3 is to inhibit signaling by IL-6 cytokine family by preventing 
JAK2-mediated activation of STAT3, which is involved in many immune diseases and 
cancer [115]. Structure-function studies have revealed the mechanism by which 
SOCS3 inhibits IL-6/JAK2/STAT3 signaling. Nadia et al. showed the crystal structure 
of a ternary complex between mouse SOCS3, JAK2 and a fragment of the IL-6 receptor 
β-chain demonstrating that SOCS3 can bind to JAK2 and the receptor at the same time 
with two opposing regions (SH2 domain and kinase-inhibitory region). SOCS3 inhibits 
the catalytic activity of JAK2 in two ways: 1. phosphotyrosine-binding groove on the 
SOCS3 SH2 domain occupies the receptor, then JAK2 can only bind in a phospho-
independent manner to a non-canonical surface; and 2. KIR of SOCS3 occludes the 
substrate-binding groove on JAK2 and thereby blocks substrate association [116, 
117], as shown in Figure 4.  
 
Figure 4:  SOCS3 binding sites on Jak and receptor 
1.3.1 STAT3 and SOCS3 in myeloid cells 
APCs have been viewed as a critical cell population in immune system, because these 
cells recognize and capture antigens, release a variety of cytokines, migrate to the 
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lymphoid organs and present to T cells in a way that triggers the immune response. In 
myeloid cells, such as macrophages and dendritic cells, STAT3 activation triggered by 
IL-6 and IL-10, can induce the pro-inflammatory and anti-inflammatory responses, 
respectively. The role of STAT3 in infection and immune diseases has been 
investigated by using stat3 gene conditional knockdown mouse model. 
Inflammatory bowel disease (IBD) is characterized by a chronic inflammation of the 
gastrointestinal tract and is subdivided into two major phenotypes: Crohn’s disease 
(CD) and ulcerative colitis (UC). IBD is defined as the class of autoimmune diseases, in 
which the immune system attacks elements of the digestive system [118].  Intestinal 
macrophages and DCs form a unique group of tissue immune cells that are ideally 
situated at the interface of the host and the enteric luminal environment to 
appropriately respond to microbes and other potential stimuli [119]. Mice with a 
conditional knockdown for STAT3 in myeloid cells (Stat3flox/flox LysMcre) displayed 
enhanced Th1 responses and developed chronic enterocolitis reminiscent of human 
IBD, with increased levels of inflammatory cytokines (TNF-α, IL-6, IL-12 and IFN-γ) 
from macrophages and dendritic cells. In vitro experiment showed that the 
suppressive effects of IL- 10 on inflammatory cytokine production were completely 
abolished in bone marrow derived macrophages or peritoneal macrophages from 
Stat3 mutant mice [120, 121]. However, development of colitis as well as STAT3 
activation was significantly reduced in IL-6–deficient mice treated with dextran 
sulfate sodium (DSS), suggesting that STAT3 plays an important role in the 
perpetuation of colitis[122]. 
Both IL-6 and IL-10 mediate pro-inflammatory or anti-inflammatory responses of 
myeloid cells respectively by signaling via the JAK2/STAT3 pathway [123, 124]. It has 
been shown that the modulation by SOCS3 of the IL-6 but not the IL-10 signaling 
pathway (SOCS3 cannot bind to the IL-10 receptor) is responsible for the contrasting 
immune responses although both cytokines utilize the same pathway [125]. 
Accordingly, IL-6 responses have been shown to resemble IL-10 responses in absence 
of SOCS3 [126]. SOCS3 is strongly induced by LPS among other innate receptor 
ligands, IL-6 and IL-10 in macrophages [127-129].  Mice that are deficient for SOCS3 in 
their myeloid cells (LysMCre-Socs3fl/fl mice) showed higher plasma levels of pro-
inflammatory M1 cytokines such as IL-1β, TNF-α and IL-6 that correlated with the 
prolonged STAT3 activation during a LPS-mediated sepsis model [130]. However, 
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mice with a conditional knockdown for SOCS3 or a mutation of the SOCS3 binding site 
in macrophages are resistant to endotoxemia due to a reduced production of 
inflammatory cytokines, which indicates that SOCS3 specifically blocks IL-6-induced 
anti-inflammatory responses [126]. In addition, Carow et al. reported that SOCS3 
expression in Mycobacterium tuberculosis-infected macrophages and dendritic cells 
(DCs) prevented the IL-6/STAT3-mediated inhibition of TNF and IL-12 secretion and 
contributed to a timely antigen-specific T cell response in vivo, which is critical for 
tuberculosis control [131]. SOCS3 has been linked to inflammation and autoimmune 
diseases, such as rheumatoid arthritis, inflammatory bowel disease and multiple 
sclerosis (MS) [132]. Experimental allergic encephalomyelitis (EAE) is an animal 
model of brain inflammation of human nervous system demyelinating diseases, 
including MS, which is an inflammatory demyelinating disease of the central nervous 
system (CNS). It is mostly used with rodents and is widely studied as an animal model 
of the human CNS demyelinating diseases[27]. By using a myelin oligodendrocyte 
glycoprotein-induced mouse model of MS, experimental autoimmune 
encephalomyelitis (EAE), Qin et al. demonstrated that mice with a SOCS3 deletion in 
macrophages exhibited enhanced STAT3 signaling, which led to the classical M1 
macrophage polarization and provided the microenvironment to up-regulate Th1 and 
Th17 cell differentiation and induced neuronal death[133]. The severity of EAE can be 
decreased by intravenous injection of M2 macrophages or SOCS3-overexpressing DCs 
that induce a Th2 cell polarization suppressing Th1 and Th17 cell differentiation[133]. 
In the contrary, mice transferred with SOCS3-deficient DCs developed a less severe 
EAE, suggesting that SOCS3-deficient DCs are immunosuppressive or less able to 
stimulate autoimmune responses in vivo [134]. 
1.3.2 STAT3 and SOCS3 in T cells 
STAT proteins and SOCS family members have been described as the necessary 
regulators for T helper cell differentiation[135], as shown in Figure 5. 
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Figure 5: STATs and SOCS proteins in T helper cell differentiation 
 
For example, STAT3 activation in response to IL-6 in combination with transforming 
growth factor-β (TGF-β) and IL-23 leads to up-regulated expression of orphan nuclear 
receptors RORγt, which is the signature transcription factor for Th17 cells[136]. The 
hyper IgE syndrome (HIES) is a primary immune deficiency characterized by elevated 
serum IgE, rash and recurrent staphylococcal infections of the skin and lung. 
Autosomal dominant HIES results from STAT3 hypomorphic mutations and has a 
variety of connective tissue and skeletal abnormalities[137]. In some cases, 
hematopoietic cell transplantation can potentially reverse the severity of HIES [138]. 
Scott et al. constructed a mouse expressing a STAT3 mutations observed in HIES. In 
this model, bone marrow transplantation partly reduced the heightened inflammatory 
responses with high levels of IL-6, TNF-α, IL-12 and IFN-γ due to a non-efficient 
STAT3/IL-10 anti-inflammatory pathway[139].  
At the same time, STAT3 has a critical pro-inflammatory role, since it is required for 
Th17 differentiation as well as IL-17 and IL-22 secretion, which ensures the 
antimicrobial peptide regenerating islet-derived protein 3 γ (Red3 γ) production and 
would control the recurrent Citrobacter rodentium infections seen in HIES [139].  
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Specifically, Th17 cells secrete different cytokines (IL-17A, IL-17F, IL-21, and IL-22) 
and their differentiation requires the activation of several transcription factors 
including STAT3 and RAR-related orphan receptor-γt (RORγt). The former is induced 
by IL-6, IL-23 and the latter by transforming growth factor-β  (TGF-β). In HIES Th17 
are thereby deficient and susceptible to infections which can be also observed upon 
mutations of IL-17 or rorgT in HIES[140].  
Follicular T helper (Tfh) cells are a subset of CD4 T cells required for the T-dependent 
germinal center (GC) formation, which leads to the production of antigen-specific 
memory B and plasma cells [141]. IL-6, IL-21 and IL-27 signal via STAT3 and are 
required for the Tfh cell differentiation and GC formation during viral infections [142-
145]. Human mutations in STAT3 as found in patients with HIES led to an impaired 
Tfh cell differentiation that could contribute to their impaired control of a variety of 
infections, including reactivation of latent viruses [145-147]. McIlwain et al. showed 
that STAT3 is involved in the maintenance of generation of T-follicular helper (Tfh) 
cells, germinal center reactions, and specific anti-virus IgG-secretion during LCMV 
infection [148]. 
Intestinal inflammation caused by pathogenic bacteria is a frequent and potentially 
life-threatening disease [149]. A meta-analysis of Crohn’s disease and ulcerative colitis 
genome-wide association scans have connected the transcription factor STAT3, which 
is widely expressed by different tissues and cell types, to intestinal pathology [150]. 
Backert et al. found that STAT3 in T cells mediated a protective role on intestinal 
epithelial cells (IECs) during infectious colitis. STAT3 promotes the Th17, Th22 cell 
differentiation and IL-17, IL-22 secretion, which stimulates IECs and promotes 
protection from enteropathogenic bacteria through maintenance of high induction 
antimicrobial peptides [151].  
The role of STATs and SOCS proteins in T helper cell differentiation has been reviewed 
previously [135]. SOCS3 has been shown to negatively regulate IL-23-mediated STAT3 
phosphorylation and Th17 polarization [152]. Recently, Th17 cells have been 
identified as one of the major pathogenic T cell subpopulations underlying the 
development of several autoimmune diseases [153]. STAT3 binds to both the IL-17A 
and IL-17F promoter [154]. By using overexpression models, SOCS3 has been 
implicated as a regulator of Th1/2 polarization via its ability to inhibit IL-12-induced 
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STAT4 activation [155, 156]. However, Chen et al. found that a deficiency for SOCS3 
had little effect on Th1/2 polarization. Instead, SOCS3 negatively regulated Th17 cells 
differentiation through the down-regulation of IL-23-induced STAT3 activation[154]. 
Loss of SOCS3 in T cells during atherosclerosis increased both IL-17 and IL-10 
production, and M2 macrophage polarization, and led to an unexpected IL-17–
dependent reduction in lesion development and vascular inflammation. This identified 
a novel SOCS3-controlled IL-17 regulatory pathway in atherosclerosis and may have 
important implications for the understanding of the increased susceptibility to 
vascular inflammation in patients with dominant-negative STAT3 mutations and 
defective Th17 cell differentiation [157]. In contrast, in a model of experimental 
autoimmune uveitis (EAU), double-producing IL-17/IFN-γ CD4 T cells were markedly 
reduced in mice deficient for SOCS3 in T cells. This suggests that SOCS3 promotes the 
expansion of the IL-17/IFN-γ T cell subset associated with development of severe 
uveitis. Thus, SOCS3 is a potential therapeutic target in uveitis and other auto-
inflammatory diseases [158]. 
1.3.3 STAT3/SOCS3 and tuberculosis 
IL-17 has been shown to be involved in the control of tuberculosis [159]. The 
frequency of Th17 cells in blood and/or pleural effusion samples of patients with 
active TB has been demonstrated to be lower than that in healthy donors or in 
individuals with latent TB infection [160]. IL-17 was involved in early Th1 cell 
recruitment, neutrophil infiltration and granuloma formation in tuberculosis patients 
[161-163]. SOCS3 is thought to inhibit STAT3-induced Th17 differentiation. 
Interestingly, SOCS3 expression in CD4 T cells can promote human CD161high Th17 cell 
polarization and IL-17 secretion during M. tuberculosis infection, which can be 
reversed by IL-7 treatment due to the down-regulation of SOCS3 expression [164]. On 
the other hand, in tuberculosis patients, PD-1 and STAT3 phosphorylation but not 
SOCS3 in CD4 T cells control the IL-23R expression and IL-17 secretion. PD-1 up-
regulation induced by M. tuberculosis can dampen STAT3 phosphorylation in T cells, 
thereby inhibiting IL-23R expression and Th17 cell differentiation [165]. 
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1.3.4 STAT3 in thymic epithelial cells 
T cell development in thymus depends on the crosstalk between thymocytes and 
stromal cells including epithelial cells, macrophages and dendritic cells [166]. Thymic 
epithelial cells (TECs) have been demonstrated to be organized in a three dimensional 
architecture, the cortex and the medulla, where T cell precursors mature and 
differentiate[167].  
Cortical epithelial cells (cTEC) regulate the early and intermediate stages for T cell 
development, including commitment of progenitors to the T cell lineage, the 
proliferation and the positive selection of developing thymocytes, selecting only those 
that recognize peptides on own MHC [21]. Medullary epithelial cells (mTEC) present 
tissue-restricted self-antigens (TRA) to delete the self-reactive T cells and preventing 
autoimmunity, which is called negative selection [37, 168]. Previous studies have 
demonstrated that the developing thymocytes and TECs interact in different manners. 
Thymocytes can express many surface or secreted molecules (CD40L, RANKL, LTα and 
LTβ), which critically control the growth and maturation of TECs[65, 66, 169-171].  
Keratin 5 is expressed in mTECs. Using K5-Cre mice to delete Stat3, Satoh et al. 
generated the mouse model with Foxn1-Cre-driven inactivation of the Stat3 locus in 
TEC and showed that the thymus from juvenile and adult mice showed a normal size 
with a reduced medulla but a normal cortex[172]. More notably, Lomada et al. 
provided a transgenic mouse model with constitutively active Stat3 transgene 
(K5.Stat3C) highly expressed in the thymic medulla, which resulted in a selectively 
expansion of MHCIIloCD80lo immature mTECs. In summary, the phenotypes from 
previous studies generated by enforcing or preventing Stat3-mediated signaling in 
TECs reveal that Stat3 activation may play a key role in TECs maintenance and T cell 
development in thymus, but still requiring more precise studies [173]. 
1.4 CISH 
Cytokine-inducible SRC homology 2 (SH2) domain protein (CISH) was the first 
member of the SOCS family to be characterized and has been shown to regulate the 
responses of immune cells to different cytokines such as IL-2, IL-3, IL-4, IL-15, GM-CSF 
and EPO[174-177]. Compared with SOCS1 and SOCS3, CISH does not have a kinase-
inhibitory region; thereby it cannot inhibit the tyrosine-kinase activity of JAK proteins 
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directly. Instead, CISH binds to phosphorylated cytokine receptors and induces the 
ubiquitin degradation of the receptor. It has been shown that CISH can bind to the 
phosphorylated second tyrosine residue (Tyr401) of the EPO receptor, which is one of 
the two major STAT5 activation sites. More notably, Cis is an ubiquitinated protein, 
which can induce ubiquitin proteasome-dependent degradation of the activated EPO 
receptors [108].  
CISH expression in CD4+ T cells has also been shown to be a negative modulator of 
STAT5 activation induced by Il-2[175, 178]. Further CISH is induced in T cells by IL-4 
and inhibits the phosphorylation of STAT3, STAT5 and STAT6. Cish-deficient T cells 
showed enhanced differentiation into the TH2 and TH9 subsets of helper T cells[179] 
and ageing CISH-/- mice showed allergic pulmonary inflammation.  
Recently, variant alleles of multiple CISH polymorphisms were found to be associated 
with susceptibility of each infectious disease. Associations of these CISH 
polymorphisms with susceptibility to infection with Hepatitis B have also been 
reported[180]. Clinic case control study performed by Khor et al. identified a panel of 
five CISH SNPs (at positions −639, −292, −163, +1320, and +3415) associated with 
increased susceptibility to bacteremia, tuberculosis, and malaria in Gambia, Hong 
Kong, Kenya, Malawi, and Vietnam[181]. Another two studies performed by Ji et al. 
and Zhao et al. showed that two of the five genetic variants (positions at -292 and 
+1320) in CISH gene appeared to increase susceptibility to TB in Chinese Han 
population[182, 183]. More notably, SNP-292 has been correlated to susceptibility in 
Chinese children[184]. The fact that CISH polymorphisms are associated with 
susceptibility to different infectious diseases suggests that CIS has a critical role in 
immune responses against various pathogens.  
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1.5 Mycobacterium tuberculosis 
 
1.5.1 Epidemiology 
Mycobacterium tuberculosis is a pathogenic bacterial species of the family 
Mycobacteriaceae and the causative agent of Tuberculosis (TB), which has existed for 
several millennia and still states a major global health problem nowadays[185]. About 
one-third of the world's population has latent TB, in other words they have been 
infected by M. tuberculosis but have not developed disease and cannot transmit the 
infection. Latent TN asymptomatic individuals have a 10% lifetime risk of developing 
TB[186]. However, individuals with a compromised immune system, such as people 
living with HIV, malnutrition or diabetes, or smokers, have a much higher risk of 
developing active TB [187]. HIV and TB form a lethal combination. Report from WHO 
for TB case in 2015 showed that there were 10.4 million new (incidence) active TB 
cases worldwide, of which 1.8 million died from the disease, including 0.4 million 
among people with HIV[188].  
1.5.2 Treatment 
A combined and lengthy antibiotic treatment (4 months Isoniazid plus rifampicin plus 
pyrazinamide plus ethambutol followed by 2 months Isoniazid plus rifampicin) is 
mandatory in cases of active TB. Since the anti-TB medicines have been used for many 
years, M. tuberculosis strains that are resistant to one or more of the drugs have 
developed. Multidrug-resistant M. tuberculosis (MDR-TB) does not respond to both 
isoniazid and rifampicin, the two most powerful, first-line anti-TB drugs[189]. In some 
cases, more severe drug resistance can develop. Extensively drug-resistant TB (XDR-
TB) is a more serious form of MDR-TB caused by bacteria that do not respond to the 
most effective second-line anti-TB drugs (fluoroquinolones (FQs) and second-line 
injectable drugs including amikacin, kanamycin, and capreomycin), often leaving 
patients without further treatment options[190].  
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1.5.3 Vaccine 
The only existing vaccine to prevent tuberculosis and other mycobacterial infections is 
Bacille Calmette-Guérin (BCG), a live strain of mycobacterium bovis developed by 
Calmette and Guerin. Although BCG effectively protects against disseminated 
tuberculosis in young children, it only shows variable protection against pulmonary 
tuberculosis probably due to the presence of environmental mycobacterium, 
differences in the strains of BCG used, presence of helminths, UV light or the host 
genetics [191]. BCG does not prevent the infection with M. tuberculosis but depending 
on the population study will reduce the development of active TB. Therefore, there is 
an urgent need for new, safe and effective vaccines that prevent against all forms of 
TB.  
1.5.4 Microbiology 
First discovered in 1882 by Robert Koch, Mycobacterium tuberculosis is a non-motile 
rod-shaped bacterium. The rods are 2-4 micrometers in length and 0.2-0.5 um in 
width. It has a tough cell wall that prevents passage of nutrients into and excretion 
from the cell, therefore giving it the characteristic of slow growth rate, with doubling 
times on the order of 18 to 24 hours[192]. This is extremely slow compared to other 
bacteria, which can divide in a matter of minutes. M. tuberculosis requires oxygen to 
grow, does not produce spores, and is non-motile. The bacillus can withstand weak 
disinfectants and can survive in a dry state for weeks. Man is the only reservoir for M. 
tuberculosis. The cell wall structure of M. tuberculosis is a major determinant of 
virulence for the bacterium and probably account for resistance to desiccation. It 
contains peptidoglycan and lipids, which consist of three major components including 
mycolic acids, cord factor, and wax-D[193]. M. tuberculosis cannot be classified as 
either gram-positive or gram-negative because it is not stained by Gram and lacks LPS. 
Due to the unique cell wall structure, M. tuberculosis is identified by using one of the 
acid-fast stain methods, which is called Ziehl-Neelsen stain[194]. More recently, other 
species of non-tuberculous mycobacteria (NTM) causing clinical disease have been 
classified. The most common organism associated with pulmonary disease is the 
Mycobacterium avium complex (MAC), a slow growing NTM that consists of many 
subspecies including silvaticum, avium, paratuberculosis, and hominissuis. M.kasassii, 
another slow growing species, is the second most common cause of pulmonary. M. 
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abscessus, a rapidly growing NTM, is the third most common cause of lung disease. 
Thus, it is important to determine the pathogenic significance of the NTMs by studying 
the patient’s clinical presentation[195]. 
1.5.5 Transmission 
M. tuberculosis is carried in small airborne droplets, called droplet nuclei. Infectious 
droplet nuclei are generated when persons, who have pulmonary or laryngeal TB 
disease, cough, sneeze, talk or sing. Depending on the environment, these particles can 
remain suspended in the air for minutes to hours after expectoration[196]. Each one 
of these droplets may transmit the disease, since the infectious dose of tuberculosis is 
very small. M. tuberculosis is only transmitted through the air, not by surface contact, 
which means the infection cannot be acquired by shaking hands, making contact with 
toilet seats, sharing food or drink, sharing toothbrushes, or kissing. M.tuberculosis 
transmission occurs when a person inhales droplet nuclei containing bacteria. These 
droplet nuclei pass through the upper respiratory tract, and bronchi to reach the 
alveoli of the lungs[197]. 
1.5.6 Experimental models 
Mycobacterium tuberculosis lacks natural hosts except humans, so surrogate models, 
which can mimic the development of the disease, are necessary to study the 
pathophysiology or design tools for treatment or prevention of the disease. There is a 
wide range of animal models of tuberculosis including mice, guinea pigs, rabbits, 
zebrafishes, minipigs and monkeys[198]. 
Mice are widely used as the animal model for tuberculosis due to many advantages 
including low cost, easy handling and gene modification, more availability for 
immunological tools and reagents[199]. Resistant strain C57BL/6 infected with M. 
tuberculosis via aerosol route can develop a steady state of infection and maintain for 
more than one year with stable bacteria load in lungs due to cell-mediated immune 
responses, which provides a perfect model to study the role of immune cells against 
infection through many well-established methods including gene manipulation and 
immunological reagent treatment[200]. However, the two most common used inbred 
laboratory strains (C57BL/6 and BALB/c) with M. tuberculosis infection mouse cannot 
develop well-structured granulomas and caseous necrosis and characteristic lesions 
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in human pulmonary tuberculosis [201]. Models including C3HeB/FeJ and CBA/J mice, 
which can form granulomas with caseating necrosis, have been developed [202, 203].  
Unlike murine infection, guinea pigs challenged with low dose M. tuberculosis by 
aerosol routine can develop the histopathology of granulomatous lesions, which is 
similar to that seen in human tuberculosis including the formation of well-structured 
granulomas, pulmonary lesions, dissemination and caseation necrosis[200]. With the 
advantage mentioned above, guinea pigs have been widely used as an animal model to 
characterize the morphologic and clinical features in human tuberculosis and anti-
tuberculosis drug development. Additionally, the guinea pig model of tuberculosis is 
used extensively in the investigation of novel vaccines, since Mycobacterium bovis 
BCG vaccination dramatically prolongs survival after low-dose aerosol infection with 
virulent M. tuberculosis [204]. 
Zebrafish embryos infected with Mycobacterium marinum, an aquatic, close genetic 
relative of M. tuberculosis, has been described in many publications as an animal for 
tuberculosis due to natural advantages including the optical transparency, abundant 
genetic tools and in vivo imaging of the progression of infection[205]. Importantly, 
zebrafish embryo lacking the functional adaptive immune system in the first weeks of 
life can provide a unique tool for visualizing the dynamics of primary granuloma 
formation and dissemination to generate new secondary granulomas mediated by the 
innate immune responses in real time[206]. 
1.5.7 Innate immune responses against M. tuberculosis   
M. tuberculosis is inhaled and traverse through the trachea, bronchus, bronchioles and 
eventually to the alveoli in the lung. Many cell types localized in the respiratory tract 
including airway epithelial cells (AECs), alveolar macrophages (AMs), dendritic cells 
(DCs), and mucus-secreting goblet cells get in contact with the bacteria. These cells 
might also constitute a first line defense against infection[197, 207]. But this has not 
been definitively established yet. 
1.5.7.1 Alveolar epithelial cells 
AECs in primary, secondary and tertiary bronchi provide a barrier that prevents 
harmful invasion through physical and immunological ways. Surfactant proteins (A, D) 
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secreted by alveolar type II cells exhibit the capacity to bind to M. tuberculosis and 
regulate the interaction between M. tuberculosis and alveolar macrophages. The 
respiratory epithelium has been shown to predominately express many pattern 
recognition receptors (PRRs) such as Toll like receptors (TLR1-9), Dectin-1, C-type 
lectin receptors (CLRs), nucleotide-binding oligomerization domain-containing 
protein 2 (NOD2), dendritic cell (DC)-specific intercellular adhesion molecule-3-
grabbing non-integrin and mannose receptor which can recognize different kinds of 
cell components (lipoproteins, LPS, flagellin, ssRNA, CpG DNA, Alpha-glucan) 
presented by M.tuberculosis mediate the host-pathogen interaction through pathogen-
associated molecular patterns (PAMPs) and trigger appropriate signaling pathways 
and subsequently release of cytokines, chemokines and antimicrobial peptides. AECs 
have been shown to play a role as antigen presenting cells (DCs and macrophages) by 
presenting M.tuberculosis antigen to major histocompatibility complex (MHC)-related 
protein 1-restricted mucosal associated invariant T (MAIT) cells and trigger them to 
produce IFN- γ, TNF -α and grazyme, which might be involved in M.tuberculosis 
clearance[208].  
1.5.7.2 Alveolar macrophages 
Alveolar macrophages (AMs) are one of the first cell types that encounter 
M.tuberculosis and play a critical role for first line defense against infection. AMs 
account for more than 90% of the cells collected from bronchoalveolar lavage and 
maintain the alveolar microenvironment by removing debris, dead cells, and 
microbes[209]. AMs also express a large number of PRRs such as the MR, TLRs, 
scavenger receptor (SR), complement receptors and Fcγ receptors, which mediate 
bacteria recognition and up-take, as well as cell activation[210, 211]. Unlike other 
macrophages populations, AMs have a high expression of nuclear receptor 
peroxisome proliferator-activated receptor-γ (PPARγ), which mediates the anti-
inflammatory immune responses by secreting PGE2 and TGF-β and IL-10 [212].  
Meanwhile, two surfactant-associated collectins, surfactant protein A (SP-A) and 
surfactant protein D (SP-D), have been shown to be involved in M. tuberculosis-AMs 
interaction, including the bacteria phagocytosis and the production of nitric oxide 
(NO), reactive oxygen species (ROS) and reactive nitrogen species (RNS) in response 
to stimuli [213].   
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Phagocytosis of M. tuberculosis by macrophages initiates a cascade of pro-
inflammatory events involving the production of cytokines which stimulate the 
activation of phagocyte anti-microbial activities (such as IL-1, IL-6, IL-10, IL-12, TNF, 
IL-23) and chemokines (such as CCL-2, 3, 4, 5, CXCL8, CXCL10, CXCL13), that recruit 
blood polymorphonuclear and mononuclear leukocytes to the site of infection [212, 
214].  
The death of macrophages, including necrosis and apoptosis, has been widely 
investigated in the pathogenesis of TB. Within M. tuberculosis-infected macrophages, 
several pro-apoptotic genes, including Fas, Bim and caspase-3, -5, -7 and -8, have been 
shown to be up-regulated and trigger the macrophage apoptosis resulting in an 
ordered degradation of cellular contents and the formation of apoptotic vesicles, 
thereby preventing the dissemination of mycobacteria [215-217]. However, in order 
to avoid apoptosis, which hampers dissemination, several M. tuberculosis proteins 
such as SecA2 and NuoG have been shown to suppress macrophage apoptosis. Instead 
of apoptosis, some virulent M.tuberculosis strains can trigger mitochondrial inner 
membrane disruption and hampering the lysosomal and Golgi- mediated plasma 
membrane repair, thereby inducing necrosis, which may be an important factor in 
granuloma formation, inflammatory tissue damage and ultimately in the 
dissemination of the bacteria within different organs and in bacterial 
transmission[207, 218]. 
Alveolar and recruited inflammatory macrophages express various PRRs including 
Toll-Like Receptor (TLR)-2, TLR-4, TLR-8 and TLR-9; C-type Lectin Receptors (CLRs), 
such as dectin-1, mannose receptor and Dendritic Cell-Specific Intercellular Adhesion 
Molecule-3-Grabbing Non-Integrin (DC-SIGN); NLRs; and Stimulator of Interferon 
Genes (STING). In addition, the complement C3 receptors (CR1, CR3 and CR4) 
expressed on macrophages surface, mediate the M. tuberculosis phagocytosis through 
the interaction with cell components such as surface polysaccharides, lower order 
phosphatidylinositol and mannosides (PIMs) and glycopeptidolipids [219, 220].  
Meanwhile, Fc receptors and scavenger receptors are also involved in mycobacterial 
recognition and endocytosis[221]. 
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1.5.7.3 Neutrophils 
Neutrophils are short-lived effector cells within the innate immune responses and the 
most abundant leukocytes in the blood[222]. Following infection, neutrophils are the 
first phagocytes to arrive from the circulation and contribute to clearance of 
pathogens [223]. Abadie et al. have shown that neutrophils infiltrate to the site of 
dermal BCG infection within 4 hours of inoculation in mice[224]. A large number of 
chemo-attractant cytokines or chemokines  (including IL-8, G-CSF, GM-CSF, MIP-2, LL-
37, LTB4, and IL-17[225]) have been suggested to participate in neutrophils 
recruitment. 
Neutrophils express TLRs, G-protein-coupled receptors (GPCR), nucleotide-binding 
oligomerization domain-like receptors, C-type lectins, Fcγ and complement receptors, 
and thereby recognize and mount responses against pathogens [226, 227].   
The killing of bacteria phagocytized in neutrophils is mediated through several 
mechanisms, including degranulation, the generation of reactive oxygen intermediates 
(ROI), and the formation of neutrophil extracellular traps (NETs), as well as many 
bactericidal peptides and proteins such as cathepsin G, elastase, defensins (e.g., human 
neutrophil proteins 1–3, HNP-1–3), cathelicidin LL-37, lactoferrin, and lysozyme[228, 
229].  
Results from studies on the neutrophil capacity to kill M. tuberculosis, in vitro and in 
vivo, are conflicting. In a study, Ramos and co-authors have shown that neutrophils 
infected with M. tuberculosis in vitro form NETs to trap mycobacteria but are unable to 
kill them[230]. The role of defensins in M. tuberculosis control has been investigated in 
several experimental studies. Martineau et al. showed that Black African participants 
(with high susceptibility to TB) had lower counts of neutrophils, as well as lower 
concentrations of circulating HNP1–3 and lipocalin 2 anti-microbial peptides than 
south Asian and white participants[231]. Cytokines and chemokines produced by 
neutrophils could mediate interactions with other immune cell types including 
macrophages, monocytes, DCs and T cells to control M. tuberculosis infection[224, 
232-234]. Whereas early after infection neutrophils play a protective role and 
contribute to early priming of T cells in the draining lymph node, neutrophils 
accumulation late during infection has been shown to mediate susceptibility to M. 
tuberculosis  (9-13).  
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1.5.7.4 Dendritic cells 
DCs are crucial cell types viewed as the bridge between innate and adaptive immune 
responses. Monocyte-derived human DCs express several receptors including 
mannose receptors, CD11b, CD11c, and DC-SIGN, all of which have the capacity to 
recognize M. tuberculosis molecules[235]. A study by Tailleux et al. has shown that DC-
SIGN expressed on human lung DCs is the major receptor mediating the M. 
tuberculosis harboring and antigen presentation via recognition of mycobacteria-
specific lipoglycan lipoarabinomannan (LAM) (ManLAM) and CCL19/CCl21 mediated 
migration, respectively[236].  Using a mouse model of TB, Wolf and co-authors have 
shown that myeloid DCs are a major cell population infected with M. tuberculosis in 
the lungs and lymph nodes. Bacteria-infected DCs in the lung are transported to the 
draining lymph node by using a CCL19/21-dependent mechanism[237]. However, 
Wolf et al. showed that delayed bacterial transported by DCs from lungs to the 
mediastinal lymph nodes resulted in delayed T cell activation[238]. 
1.5.7.5 Natural killer cells 
Natural killer cells or NK cells are a type of cytotoxic lymphocyte critical to the innate 
immune system. The natural cytotoxicity receptor (NCR) NKp44 expressed on NK cells 
can directly bind to mycolic acids, a critical component of M. tuberculosis   cell 
wall[239]. In human TB, several studies have been shown to investigate the function 
of NK cells in TB control. Zhang et al. showed that M.tuberculosis activated NK cells can 
improve γδ T cell proliferation both via CD54-mediated cell-cell contact through the 
formation of immune synapse and pro-inflammatory cytokines including TNF-α, GM-
CSF, and IL-12[240]. In addition, another study from Vankayalapati et al. 
demonstrated that activated human NK cells release IFN-γ, which triggers the 
secretion of IL-15 and IL-18 by M. tuberculosis infected monocytes, thereby 
maintaining the frequency of M. tuberculosis-responsive CD8+IFN-γ+T cells[241]. 
Meanwhile, they also showed that human NK cells could lyse M. tuberculosis-infected 
monocytes and macrophages depending on the NKp46 expression[242]. However, 
another murine study by Junqueira et al. showed that mice with NK cell depletion 
using NK 1.1 antibody displayed a comparable bacteria load in lungs after 
M.tuberculosis infection[243]. 
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1.5.8 Adaptive immune responses against M. tuberculosis 
The adaptive immune responses are critical for the control of M. tuberculosis-infection 
in humans. T cells are of special importance for M. tuberculosis control. The 
mechanisms involved in the initiation of CD4+ T cell response to M.tuberculosis 
infection have been discussed in many studies using the murine infection model.  
After aerosol infection, DCs in the lung will phagocytose M. tuberculosis and migrate to 
the lung-draining lymph node (also termed mediastinal lymph node, MLN), where T-
cell priming can occur. A study by Khader et al. has demonstrated that mice lacking IL-
12p40 fail to generate activated CD4+ T cells after M. tuberculosis   infection, which is 
associated with the absence of expression of the chemokine receptor, CCR7 on DCs 
[244]. This is surprising since IL-12/ IL-23 (of which IL-12p40 is part of) are known to 
participate in the differentiation of Th1 or Th17 rather than in the migration of these 
cells. 
Later, using the GFP-expressing M. tuberculosis, Wolf et al. showed that more than 
65% of the infected cells in the MLN were CD11chighCD11bhigh myeloid DCs, which 
resemble the predominant infected cell population in the lungs. Surprisingly, Wolf and 
co-authors also showed that M. tuberculosis-infected DCs in MLN showed impaired 
activation of naive M. tuberculosis-specific CD4+ T cells. This was partially due to low 
expression levels of MHC class II[237]. On the other hand, Srivastava et al. showed 
that infected migratory DCs could release soluble and unprocessed M. tuberculosis 
antigens, which could be taken up and presented by uninfected resident lymph node 
DCs[245].  
1.5.8.1 IFN-   
It is well established that IFN-γ and TNF, expressed by Th1 CD4+ T cells, activate 
effector functions in macrophages that control intracellular M.tuberculosis. Mice with 
defect on CD4 T cells, IL-12, IFN-γ, or T-bet are highly susceptible to TB. People with 
inborn defects in the IL-12/ IFN-γ pathway, as well as individuals who raise anti- IFN-
γ neutralization antibodies are extremely susceptible to mycobacterial infections 
[246]. They are especially susceptible to atypical commensal mycobacteria as well as 
to BCG.  Green et al. showed that IFN-γ from CD4+ T cells is essential for the control of 
M. tuberculosis infection. By using a murine adoptive transfer model in which all cells 
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were capable of producing IFN-γ except CD4 T cells, they proved that IFN-γ secreted 
by CD4 T cells were required for host survival and long-term control of bacterial 
burden. Moreover, IFN-γ from CD4 T cells was necessary for a robust CD8 T cell 
response[247].  
However, some evidence also indicates that while IFN-γ is required for bacterial 
control, increasing IFN-γ responses do not necessarily result in increased resistance to 
TB. Tsao et al. showed that TB patients with more severe pulmonary involvement, 
fever or body weight loss, had significantly higher bronchoalveolar lavage (BAL) fluid 
levels for IFN-γ and sIL-2Ra compared to those with a milder disease [248]. Cowley et 
al. found that CD4+ T cells controlled >90% of intracellular M. tuberculosis   growth in 
the complete absence of IFN-γ activated macrophages through NO-dependent 
pathway[249]. Furthermore, BCG vaccinated IFN--deficient mice exhibited significant 
protection against M. tuberculosis challenge that was lost upon depletion of CD4+ T 
cells, suggesting that CD4+ T cells possess IFN- independent mechanisms that are 
dominant in secondary responses to M. tuberculosis. 
Furthermore, it was shown that M. tuberculosis antigen-specific effector T cells with 
defects in IFN-γ, TNF, Tbet, perforin or FAS could perform effectively control of M. 
tuberculosis infection after transferred into mice [250]. In summary, these findings 
demonstrate that CD4+ T cells also possess IFN-γ-independent mechanisms that can 
limit the growth of M. tuberculosis. 
The characteristic of the T cell elicited responses is critical for containment of M. 
tuberculosis. Several clinical studies have investigated whether trifunctional (secreting 
at least three cytokines) versus mono- and bifunctional (secreting 1 or 2 cytokines) 
CD4+ T cells are relatively increased in LTBi or in TB disease. Harari et al. showed that 
the frequency of TNF single-positive M. tuberculosis -specific CD4+ T cells was 
associated with active TB[251]. In addition, patients with active TB exhibited lower 
frequencies of trifunctional IFN- TNF- and IL-2-secreting M. tuberculosis-specific 
CD4+ T cells, compared with smear negative or latent infected individuals. 
Furthermore, upon anti-TB antibiotic treatment, specific IFN-γ+IL-2+TNF-α+ poly-
functional CD4+ T cells increased, whereas TNF and IFN-γ-single positive T cells 
decreased [252, 253]. 
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The ability of T cells to migrate from circulation to the lung parenchyma is critical for 
their protective capacity during M. tuberculosis infection. Several murine studies have 
investigated the immune responses against infection mediated by M. tuberculosis -
specific Th1 subsets including PD-1+CXCR3+ T cells localized in lung parenchyma 
with poor IFN-γ expression capacity, and KLRG1+CXCR1+ T cells localized to the 
vasculature with high IFN-γ secreting capacity [254-256]. Surprisingly, mice 
adoptively transferred with PD1+ CD4 T cells showed much better control against M. 
tuberculosis infection compared to the KLRG1+ (which labels effector T cells), 
suggesting that the control of M. tuberculosis correlates with the ability of CD4+ T cells 
to efficiently enter the lung parenchyma rather than produce high levels of IFN-
γ[256]. 
1.5.8.2 IL-17 
Over the past decade, a number of studies have analyzed the role of IL-17-producing 
cells (Th17 cells) in the control of M. tuberculosis infection. Th17 cells development is 
initiated by IL-6 and TGF-β, required for the expression of the orphan nuclear 
receptor RORγt via signal transducer and activator of transcription 3 (STAT3), which 
induces the expression of the receptor for IL-23. Then the binding of IL-23 stabilizes 
the Th17 phenotype[257]. The data referring to the role of Th17/IL-17 during 
primary M. tuberculosis infection are conflicting. Several studies have described that 
Th17 cells are involved in immune protection against M. tuberculosis, primarily due to 
the effect of Th17 signature cytokines in attracting and activating monocytes and Th1 
cells [258]. An early study by Khader et al. reported that IL-23 had relatively minor 
effects in the infection control of M. tuberculosis but was essential for generation of 
specific Th17 cells[259].  
IL-23 was found to be required for long-term control of M. tuberculosis infection 
through its ability to support the expression of CXCL13 in B cell follicles. This 
chemokine promotes the infiltration of T cells into the lesion[260]. By using mice 
deficient in the IL-17 receptor A subunit (IL-17RA-/- mice), Freches et al. showed that 
IL-17RA deficient mice were not to able to mediate long-term control of M. 
tuberculosis infection, as demonstrated by a progressively increasing pulmonary 
bacterial burden and shortened survival times. Early but not late neutrophils 
recruitment was impaired in IL-17RA-/- mice, which indicated that neutrophil 
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recruitment in early infection phase was necessary for IL-17A-mediated long-term 
control[261]. It has been reported that mice with IL-17 deficient were not able to 
control infection by the hyper-virulent M. tuberculosis strain HN878, associated with 
CXCL13 induction, lymphoid follicle formation and macrophage activation [163].  
Furthermore, Monin et al. showed that adoptively transferred M. tuberculosis-specific 
Th17 cells mediated the recall responses that displayed the protection at levels similar 
to vaccination strategies. They found that CXCR5 expression on adoptively transferred 
Th17 cells could regulate the localization of Th17 cells near macrophages within well-
formed B cell follicles to mediate M. tuberculosis control in a IL-23/IL-17 dependent 
pathway, which identify new immune characteristics by targeting on Th17 recall 
responses for enhancing vaccine design against TB[262].  
Murine studies reported that, early after infection, IL-17 was mainly produced by γδ T 
cells, which induce neutrophils infiltration and mature granuloma formation (180, 
181). Furthermore, it was shown that IL-17 was required to induce optimal Th1/IFN-
γ and delayed type hypersensitivity (DTH) responses against BCG infection[161, 263, 
264].  
Besides IL-17, IL-22 is also a cytokine secreted by Th17 cells. IL-22 can contribute to 
immune disease through the stimulation of inflammatory responses, S100s and 
defensins expressed by epithelial cells in the lung. The role of IL-22 in the control of M. 
tuberculosis infection has been investigated in several murine and human studies. A 
clinical investigation by Liu et al. found that the proportions of IL-22 T cells in patients 
with active TB were higher than those with the latent TB infection and the healthy 
control group[265]. In addition, Matthews et al. showed that IL-22 but not IL-17 was 
abundant in pleural or pericardial fluid from HIV negative TB patient, correlated 
positively MMP-9, a metalo peptidase known to degrade the pulmonary extracellular 
matrix [266]. Both of these studies indicated that IL-22 probably was involved in TB-
induced pathology or the ensuing repair process. Besides Th1, Th17 and CD8 T cells, 
NK cells from TB patients produced Il-22[267], which activates macrophages. IL-22 
enhanced phagolysosomal fusion and reduced M. tuberculosis growth in macrophages 
[268]. However, Behrends et al. have demonstrated that IFN-γ+ Th1 cells produce IL-
22 early after infection of mice with M. tuberculosis, and that the absence of IL-22 does 
not affect the outcome of infection with M. tuberculosis, including the bacterial load in 
different organs, immune cells infiltration and cytokine expression [269]. 
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Several studies suggested the involvement of Th17 cells in TB pathology. Th17/IL-17 
induce the expression of chemokines and cytokines on many immune cell types, as 
well as the recruitment of neutrophils that promote local inflammatory responses and 
may lead to serious tissue damage[270]. Jurado et al. found that, compared with BCG-
vaccinated healthy control, IFN-γ responses from T cells from TB patients were 
reduced significantly, and IL-17 were markedly augmented. The main source of IL-17 
was CD4+IFN-γ+IL-17+ T cells, and the IL17-level in blood and pleural fluid from TB 
patients correlated positively with the disease severity [271]. Furthermore, Marin et 
al. have measured the frequencies of IL-17 and IFN- γ producing cells in patients with 
active TB, LTBI, and healthy control individuals. They found that the frequency of IFN-
γ+ CD4 T cells was elevated in LTBI, and the percentage of IL-17+ CD4 T cells was 
higher in TB patients suggesting that active TB could modify the protective Th1 
responses toward the pathological Th17 responses[272]. 
1.5.8.3 CD8+ T cells 
A number of M. tuberculosis proteins, such as Ag85A, Ag85B, Ag85C, ESAT6 and 
CFP10, are recognized by human CD8+ T cells[273-277]. Several hypothesizes about 
the mechanisms for the recognition of M. tuberculosis antigens by CD8+ T cells have 
been presented in a number of studies after expression of antigen candidates in the 
cytosol of APC or screening the M. tuberculosis genomic sequence to identify peptide 
epitopes that are likely to bind to class I MHC proteins[278]. In infected APCs, Sec61, 
which mediates retrograde protein translocation, could translocate proteins secreted 
by M. tuberculosis from the phagosomal compartment across the phagosomal 
membrane into the cytosol where they could enter the class I MHC processing 
pathway. The cross-presentation of mycobacterial antigens by DCs could also lead to 
CD8+ T cells priming. Apoptotic vesicles from M. tuberculosis-infected macrophages 
could have been taken up by uninfected DCs, and peptides processed in the 
proteasome and presented on MHC-I molecules [278-281]. 
CD8+ T cells could mediate protection against M. tuberculosis infection by several 
mechanisms. CD8+ T cells from TB patients have been shown to secrete diverse pro-
inflammatory cytokines, including IFN-γ, IL-17, TNF and IL-2 [282].  In addition, a 
hallmark of CD8+ T cells in many immune responses is the cellular cytotoxicity, which 
can be mediated by several mechanisms including the release of cytotoxic granules 
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containing perforin and granzymes and Fas/FasL dependent killing and TNF induced 
cell death[278]. Moreover, human CD8+ T cells and NK cells can produce granulysin, a 
microbicidal protein in cytotoxic granules, and can directly interact with microbial cell 
wall and/or membrane, leading to increased permeability and lysis[283]. Ernst et al. 
reported that granulysin increased the permeability of bacterial membranes based on 
its ability to allow access of cytosolic β-galactosidase to its impermanent substrate. 
They found that granulysin triggered fluid accumulation in the periplasm of M. 
tuberculosis using electron microscopy[284]. 
To investigate whether CD8+ T cells mediate a protective role during M. tuberculosis 
infection, many strategies such as CD8+ T cell depletion by antibodies, CD8 knockout 
mice, and adoptive transfer of CD8+ T cell have been used.  β2m-/- mice, which lack 
CD8+ cells due to a defective presentation in the thymus, infected with virulent M. 
tuberculosis did not survive 6 weeks after infection, and showed uncontrolled 
bacterial burden and caseating necrosis in the lungs. This suggested that functional 
CD8 T cells and/or other T cells that require presentation via MHC-I for maturation, 
protect against M. tuberculosis infection [285]. Other knockout mouse models lacking 
CD8 T cells such as the tap1-/-, cd8a −/− and KbDb −/− mouse models showed that CD8+ 
T cells have a crucial role in immunity against M. tuberculosis infection[286-289]. 
Moreover, Tascon et al. showed that M.tuberculosis infected athymic nude mice, 
adoptively transferred with naïve wild type CD8+ T cells but not IFNγ −/− CD8+ T cells, 
could control the bacterial burden in lungs and spleen, indicating that IFN-γ-
producing CD8 T cells contributed to the bacterial control[290]. In addition, Müller et 
al. showed that depletion of CD8+ T cells in thymectomized mice prior to M. 
tuberculosis infection (i.v.) displayed uncontrolled bacteria growth in the spleen 3 
weeks after infection[291]. However, two other studies performed in a similar way 
found that depletion of CD8+ T cells did not affect the control of BCG replication, 
which probably indicates that CD8 T cells are involved in the control of virulent 
bacterial strain infection[291, 292]. Moreover, the increased susceptibility of β2m-/- 
mice over MHC-I-/- mice which actually do not show increased bacterial load 
compared to controls has been coupled to defective iron overload, which represents 
an exacerbating cofactor for TB. 
The relative importance of CD8 and CD4 T cells in anti-M. tuberculosis immunity can 
be only performed on mice of the same age and sex by using the same infection dose 
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and time period in an aerosol infection chamber. A comparative study of the ability of 
MHC class I−/− and class II−/− mice to defend against M. tuberculosis infection showed 
that MHC class II-dependent immunity is much more important [293].  
Several studies have demonstrated the presence of regulatory CD8+ T cells 
subpopulations. In CBA/J mice, Cyktor et al. found that clonally expanded (TCR Vβ8+ 
or 14+) CD8 T cells displayed an immunosuppressive phenotype (PD-1+, Tim-3+, 
CD122+) and were able to produce IL-10. However, depletion of Vβ8+CD8 T cells did 
not alter the outcome of infection with M. tuberculosis [294]. Furthermore, a clinical 
study by Silva et al. observed the presence of IL-10/TGF-β and low levels of granzyme-
B expression in CD8+ T cells. This was correlated with increased bacterial load in 
sputum in active TB patients, providing a new insight into another role for CD8+ T 
cells in TB [282].  Mucosal-associated invariant T cells (MAIT), a MR1-restricted non-
classical CD8 T cell subpopulation enriched in airway, can recognize M. tuberculosis 
antigen presented by airway epithelial cells and release several cytokines such as IFN-
γ and TNF-α. The role of MAIT cells contribution to the host response against M. 
tuberculosis infection is not well known yet[295]. 
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2 MATERIAL AND METHODS 
The methods applied in our studies are described in detail in the published articles and in the 
manuscript. I want to give an overview about the genetically modified mice that have been 
used. 
Mouse strain type of modification effect 
Stat3fl/fl LysM cre* conditional knockdown excision of the Stat3 gene in 
myeloid cells 
Socs3fl/fl LysM cre* conditional knockdown excision of the Socs3 gene in 
myeloid cells 
Socs3fl/fl cd11c cre* conditional knockdown excision of the Socs3 gene in 
CD11c+ cells 
Gp130F/F knockin mutation of the SOCS3 binding site 
in gp130 in all cells 
p25-tg rag1-/- ECFP knockout no mature CD8 T cells and B cells, 
only CD4 T cells that express ECFP 
and with trancgenic TCR only 
recognizting P25 peptide from 
antigen 85B 
p25-tg socs3fl/fl lck cre* Knockout and conditional 
knockdown 
no mature CD8 T cells and B cells, 
only CD4 T cells that express ECFP 
and with trancgenic TCR only 
recognizting P25 peptide from 
antigen 85B and excision of the 
Socs3 gene 
p25-tg stat3fl/fl lck cre* Knockout and conditional 
knockdown 
no mature CD8 T cells and B cells, 
only CD4 T cells that express ECFP 
and with trancgenic TCR only 
recognizting P25 peptide from 
antigen 85B and excision of the 
Stat3 gene 
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Il12p40
-/-
 knockout disruption of the Il12p40 gene in all 
cells no IL-12  and IL-23 expression 
Socs3fl/fl actin creER inducible conditional 
knockdown 
excision of the Socs3 gene all cells 
after tamoxifen treatment 
Cish
-/-
 knockout disruption of the Cish gene in all 
cells 
Socs3fl/fl cd4 cre* conditional knockdown excision of the Socs3 gene in  CD4+ 
cells 
Socs3fl/fl lck cre* conditional knockdown excision of the Socs3 gene in T cells 
Rag1
-/- 
knockout disruption of the Rag1 gene in all 
cells no mature B and T cells 
 
*Conditional knockdown: 
Mice were generated using the Cre-lox combination system, in which the Cre DNA 
recombinase is expressed under a cell-specific promoter. Although the target gene is flanked 
by LoxP sequences in all cells for recognition by the Cre enzyme, it will only be deleted 
specifically in Cre-expressing cells. 
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3 RESULTS AND DISCUSSION 
PAPER I: ROLE OF SOCS3 IN T CELL DEVELOPMENT IN THYMUS 
 
T cell development in thymus depends on the crosstalk between thymocytes and stromal cells 
such as thymic epithelial cells and dendritic cells. Such cellular communication takes place 
through cell contact and by cytokines[296].  
Since SOCS3 is a major regulator of immune responses by regulating the responses to 
cytokines and growth factors, we hypothesized that SOCS3, may play a role in T cell 
development in thymus.  
Deletion of SOCS3 in vivo has important effects on placental development, inflammation and 
insulin sensitivity.  Genetic defect of SOCS3 leads to mid-gestational embryonic lethality due 
to increased STAT3 and MAP kinase activation [297]. Lack of suppression of LIF and fetal 
erythropoiesis signaling had been shown to account for the lethality of Socs3
-/-
 mice [297]. 
LIF belongs to the IL-6 family and is involved in blastocyte implantation.  
Thus, to study the effect of SOCS3 in T cell development in the thymus, we generated a 
tamoxifen-inducible conditional SOCS3 knockdown, using an actin promotor for the estrogen 
receptor activated Cre recombinase described in other studies [298]. Previous to this study, 
the expression of SOCS3 in thymocytes subpopulations has been shown (reference), while 
the effect of SOCS3 deletion in thymocytes differentiation using a OP9-l1 system was 
relatively minor[299].  
 We found that the thymus from mice with SOCS3 deletion displayed an extraordinary 
atrophy, as well as reduction of cellularity. The frequency of DP cells among thymocytes was 
also diminished. Moreover, the percentage of activated (CD44
high
) CD4+ and CD8+ T cells in 
peripheral lymphoid organs were increased, which was probably because of the defective 
output of naïve T cells from thymus resulted in a lymphopenia-induced homeostatic 
proliferation of naïve T cells which in absence of antigenic stimulation will acquire T cell 
memory markers.  
We performed many controls for these experiments. Controls included testing different doses 
of tamoxifen, the use of socs3
fl/fl  
 as well as actin cre ER mice to control for possible off 
targets effects of cre (as decribed below for lck cre), or for toxicity of Tamoxifen.  
The tamoxifen-mediated activation of cre under actin promoter results in the deletion of socs3 
gene in all cell populations[300]. Thus, we investigated whether SOCS3 expression in either 
bone marrow-derived vs or non-hematopoietic cells is involved in T cell development. For 
this purpose, we generated bone marrow radiation chimeras socs3socs3fl/fl   and 
administrated them with Tm after reconstitution. We found that the SOCS3 deficient 
recipient mice adoptively transferred with bone marrow cells from wild type donors 
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displayed a defect T cell development similar to what was observed in the socs3 mice, 
which strongly suggested that SOCS3 expression in thymic stromal cells but not in 
hematopoietic cells are required for T cell development in the thymus, as shown in Figure 6. 
The lack or minor participation of SOCS3 expression in hematopoietic cells was confirmed in 
socs3
fl/fl
 cd4 cre and socs3
fl/fl
 lck cre mice (deficient in SOCS3 in T cell populations at the DP 
stage and the DN2 respectively), in which T cell development in thymus was similar to non-
mutant controls. 
 
 
Figure 6: Representative dot plots of DN, DP, CD4 SP and CD8 SP thymocytes in bone 
marro
fl/fl 
mice (at least 5 per group) treated with Tm.  
In the thymus diverse populations of thymic epithelial cells (TECs), including cortical and 
medullary TECs and their subpopulations, have distinct roles in coordinating the 
development and repertoire selection of functionally competent and self-tolerant T cells.  
These are characterized by a diversity of cell surface markers. We showed that that the 
thymic cortex and medulla of SOCS3 deficient mice was disorganized and the boundaries 
between them were not clear (Figure 7).  
Both cTECs and mTECs are CD45- cells that express MHCII and EpCAM[301, 302]. They 
can be identified based on expression of specific proteins and surface markers. cTECs 
express keratin 8 (K8) and Ly51, whereas mTECs express keratin 5 (K5) and ulex europeus 
agglutinin-1 (UEA-1). cTECs can be divided into two subpopulations based on the 
expression of K5, a major population K8-K5+ and a miner population K8+K5+.  On the other 
hand, mTECs can be separated in immature and mature subsets depending on the expression 
level of MHC II and CD80, as well as the autoimmune regulator (AIRE)[303, 304]. To 
identify the cTEC and mTEC in thymus, we performed the immunohistochemistry staining 
by using the anti-K8 and anti-K5 antibodies, which will characterize cTEC and mTEC, 
respectively. We found that the fraction of area with an overlapping staining was more 
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extense in SOCS3 deficient mice, as shown in Figure 7, which is accordance with the 
histological observation of a less defined interface.  
Mature cTEC and mTEC mediate the positive and negative selection on DP and SP cell 
stage, respectively [305]. In our study, we also used several surface markers discussed above 
to define immature and mature TECs by flow cytometry and found a diminished frequency of 
mature cTECs (defined as for lower levels of MHCII) and mTECs, which probably indicates 
a defective role in positive and negative selection. A reduction of levels of IL-7 and the 
reduction of MHCII observed may contribute to this. Importantly, the numbers and 
frequencies of mTECs and cTECs in mutant and control mice were similar.  
 
Figure 7: H&E staining (E) and keratin-5 and -8 staining (F) labelling the depicting the 
higher disorganization of thymi from Δsocs3 as compared to control mice. 
Gp130, the common IL-6 receptor family, is expressed on thymocytes and TECs [306, 307] 
and has been shown to be required for proper thymic formation[308]. SOCS3 binds to gp130 
and hampers STAT3 signaling altering the responses of macrophages and T cells to infection 
or to innate receptor agonists [309]. However, gp130
F/F
 mice with a mutation that impairs 
SOCS3 binding, displayed normal thymus structure and thymocyte numbers and frequencies, 
which indicated that SOCS3 signaling via gp130 is redundant for thymopoiesis. 
Several molecular mechanisms and signaling pathways in involved in TECs development 
have been reported. Transcription factor FOXN1[53] and Notch1/DLL4 mediated signaling 
pathways are required for cTEC differentiation cTEC development[51, 52]. The secretion of 
IL-7 is probably also mediated by Notch1 pathways and mediates -selection. On the other 
hand, RANK/RANKL, CD40/CD40L, LTα/β mediated downstream signaling pathways 
including NFκB are considered critical for mTECs differentiation[63].  
In order to identify molecular mechanisms that are altered in SOCS3 deficient TECs and that 
might regulate T cell development in thymus, we sorted the TECs and analyzed the 
transcripts by using microarray analysis. The assay identified 9392 transcripts expressed 
above threshold level in both groups and 703 transcripts were picked up because of 
differently expressed between groups, 367 higher and 336 lower in SOCS3 deficient than in 
WT TECs. A GO analysis indicated several pathways being altered including cytokine-
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cytokine receptor interaction and epithelial-mesenchymal transition pathways. We found that 
the growth factor and receptor transcripts such as fgf9 and fgfr2 were significantly higher in 
WT TECs, which could be an explanation for the better TECs development in WT nice as 
shown above. IL-7 expressed by TECs is critical for the thymopoiesis in the early DN 
stages[310]. We found IL-7 mRNA level was reduced in SOCS3 defect TECs compared to 
controls. On the other hand, IL-7R expression level was increased in SP cells from SOCS3 
deficient, probably as a response to low IL-7 levels.  
Antigen presentation by TECs is critical for positive and negative selection. We found MHC 
II mRNA level was significant lower in SOCS3 deficient TECs, probably indicating a defect 
in position and negative selection for DP and CD4 SP cells. However, genes involved in 
mTEC development and central tolerance including Aire, CD40, CD80, several from the 
MHC-II locus and cathepsin M and L (involved in antigen presentation), chemokines and 
their receptors that mediate migration of thymocytes during thymic development, and 
members of the TNF-receptor family that mediate thymocyte development such as CD30 or 
rank were elevated in the SOCS3 deficient TECS as compared to the controls.  
Many questions remain with regards to the role of SOCS3 in T cell maturation in the thymus. 
Among these, we believe the identification of the SOCS3 binding partner(s) in TECs that 
account for thymic atrophy and the defective T cell differentiation. Further, whether the 
alterations observed mainly affect positive or negative selection is at this time unknown. The 
fact that DN cells shows defective BrdU incorporation and show a relative accumulation in 
the socs3 mice, as well as the blockade in SP differentiation, shows that a defect early in 
thymocytes in the thymic cortex is likely. The same is suggested by the reduced levels of IL-7 
found in TECs mirrored by the abnormal frequency of  vs  TCR + cells.  
Other questions as the role of SOCS3 in the generation of Treg in the thymus should also be 
addressed here.  
Inflammation and the production of stress hormones cause thymus regression. SOCS3 
deficient mice in hematopoietic cells show inflammatory responses during their adult life. 
The relative short time period from Tm administration to analysis and the lack of obvious 
sings of inflammation (increased size of lymph nodes or spleens) suggests that this is not 
probable cause.  
Overall, we here show that SOCS3 plays a central role in maintenance of the thymic 
architecture, the maturation and morphology and tissue distribution of TECs and in the 
differentiation of T cells in the thymus. SOCS3 expression in T cells is central for their 
proper differentiation and function. Our results indicate that SOCS3 regulation in TECs 
provides proper niches for thymocytes maturation, and consequently is required for proper 
thymocytes development and naïve T cell export in the periphery.   
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PAPER II. ROLE OF STAT3 EXPRESSION IN MYELOID CELLS IN THE 
CONTROL OF M. TUBERCULOSIS INFECTION 
 
As indicated in the introduction to the thesis STAT3 and SOCS3 are main controllers of 
immunity and inflammation.  
Previous data showed that SOCS3 expression in myeloid cells is required for the control of 
M. tuberculosis infection since it modulates and IL-6/gp130/STAT3 signaling pathway to 
induce IL-12p40 expression in APCs and lead to timely T cell mediated protection [131]. 
Of importance, while it was obvious that SOCS3 in myeloid cells acted on T cell 
mediated immunity the defined mechanisms regulated are unknown. In this study, we 
investigated the role of STAT3 expression in myeloid cells in regulation of M. 
tuberculosis infection.  
First, the role of STAT3 expression in myeloid cells in the control of infection with M. 
tuberculosis was examined using stat3
fl/fl
 lysm cre mice. Mice with STAT3 deficiency in 
myeloid cells (stat3
fl/fl
 lysm cre) showed significant lower bacteria burden in lungs and 
spleens after 4 and 8 weeks of infection, compared with the stat3
fl/fl
 littermates. The area 
occupied by granuloma in the lung of stat3
fl/fl
 lysm cre mice was reduced at 4 weeks after 
infection. Meanwhile, we found that the neutrophil density and the levels of neutrophil 
myeloperoxidase and elastase mRNAs were higher in lungs from stat3
fl/fl
 lysm cre mice at 4 
and 8 but not at 14 weeks after infection with M. tuberculosis-infected mice compared to 
controls. Neutrophil accumulation during late phase of infection have been associated with 
susceptibility to M. tuberculosis mediated by the excessive pro-inflammatory response and 
tissue damage, whereas early after infection neutrophils play a protective role and contribute 
to early priming of T cells in the draining lymph node[311, 312].  
Several studies have reported that neutrophil mobilization during inflammation was mediated 
by G-CSF inducing CXCR2 up-regulation via STAT3 signaling pathway[313, 314]. In this 
case, we thought that the increased pulmonary neutrophils infiltration during M. tuberculosis 
infection was not a direct consequence of STAT3 deficiency in these cells.  
Il-17 has been shown to stimulate the expression of chemokines required for neutrophil 
recruitment [315]. In agreement with this hypothesis, we found that the frequency of IL-17 
secreting mycobacteria-specific CD4+ T cells, but not of γδ+ T cells, were elevated in the 
lungs from stat3
fl/fl
 lysm cre mice compared to controls, as well as the il-6, il-23, il-17, and il-
22 genes transcription level in lung tissue. While IL-6 and IL-23 are important for Th17 
differentiation and maintenance, the increased IL-17 and IL-22 levels might participate in the 
elevated neutrophil levels in lungs from stat3
fl/fl
 lysm cre M. tuberculosis-infected mice.  
Next, we studied whether STAT3-deficient macrophages (BMMs) showed impaired 
intracellular bacterial growth. BMM from stat3
fl/fl
 lysm cre mice expressed higher level TNF-
α. Surprisingly, the intracellular bacteria levels in stat3fl/fl lysm cre and control BMMs 
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were similar, which indicated that the increased bacteria control in vivo was not 
generated by the macrophages mediated innate immune responses. 
On the other hand, BMMs or bone marrow derived dendritic cells (BMDC) from STAT3 
deficient mice also showed increased il-6 and il-23 mRNA levels after mycobacterial 
stimulation. In addition, in a co-culture system, mycobacterial stimulated BMDC with 
STAT3 deficient promoted antigen-specific T cells to secrete more IL-17, as compared with 
WT controls. To our knowledge, this is the first report showing that STAT3 deficiency in 
myeloid cells promotes IL-17 secretion by antigen-specific T cells in vitro and in vivo, which 
was associated with the increased secretion of TH17 differentiation cytokines including IL-6 
and IL-23 by STAT3-deficient APCs.  
The increased expression of IL-6 and IL-23 in stat3
fl/fl
 lysm cre APCs was not restricted to the 
infection with attenuated or virulent mycobacterial since, it was observed after incubating 
mutant APCs with different TLR agonists or bacterial lysates, confirming previous data[316]. 
The opposite effect was observed using socs3
fl/fl
 lysm cre BMM, which were poor inducers of 
IL-17 secretion by mycobacteria-specific T cells. In relation to this, DCs that secrete IL-
12p40 (required for T cell differentiation into Th17 or Th1) in the lymph nodes of 
mycobacteria infected mice are primarily uninfected[317]. 
We showed that the improved M. tuberculosis control in stat3
fl/fl
 lysm cre mice is IL-17-
mediated, since administration of neutralization anti-IL-17RA antibodies abrogated 
differences in bacterial burden between mutant and control mice, as well as the neutrophils 
infiltration shown by mpo transcript analysis. IL-17 might contribute to long-term protection, 
control of infection after vaccination or control of hyper-virulent strains of M. tuberculosis. 
IL-17 has been also shown to mediate CXCL13 induction in the lung, a chemokine that 
contributes to the localization of pro-inflammatory cytokine-producing CXCR5+ T cells 
within lymphoid structures, promoting those macrophage activation and mycobacterial 
control[162, 163, 318-320]. 
Finally, the role of STAT3 in myeloid versus T cells in regulation of antigen-specific IFN-γ 
and IL-17 T cell responses was compared. Contrary to the role of STAT3 in APCs, IL-17 
secretion was hampered in mycobacteria-specific STAT3-deficient T cells. STAT3 is 
required for the responses to IL-6, IL-21 and IL-23 and for the expression of RORγt by T 
cells [134]. Instead, SOCS3-deficient antigen-specific T cells secreted higher IL-17 levels as 
previously reported in other systems[154], while IFN-γ responses were inhibited. Thus, while 
the role of STAT3 in T cells in the control of M. tuberculosis remains to be studied, these 
results illustrate the pleiotropic effect of STAT3 in regulation of infection-induced immune 
responses in different cell types.   
Taken together, we here showed using SOCS3- and STAT3-deficient mice that STAT3 in 
myeloid cells is detrimental for the control of infection with M. tuberculosis. SOCS3 acts as a 
mirror of STAT3 in this model. Surprisingly, this occurs via impairing secretion of IL-17 by 
antigen-specific T cells, as shown in Figure 8. 
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Figure 8:  Signaling pathways mediated by STAT3 and SOCS3 in APCs affect the outcome 
of M. tuberculosis infection 
  
Control BCG Ag85b peptide
0
10
20
30
40
IF
N
-g
 (
n
g
/m
L
)
***
Control BCG Ag85b peptide
0.0
0.1
0.2
0.3
IL
-1
7
(n
g
/m
L
)
***
***
Control BCG Ag85b peptide
0.0
0.1
0.2
0.3
0.4
IL
-1
7
(n
g
/m
L
)
***
**
Control BCG Ag85b Peptide
0
4
8
12
IF
N
-g
 (
n
g
/m
L
)
***
***
A B
C D
STAT3	
deficient
Wild	type
SOCS3
deficient
pSTAT3
pSTAT3
SOCS3
SOCS3
IL-6
IL-23
IL-23
IL-6
IL-6
IL-23
IL-17
IL-17
IL-17
TLR
TLR
gp130
Increased	
M.tb control
Increased	
levels	of	
neutrophils
TLR Decreased	
M.tb control
Reduced		priming	
of	mycobacteria	
specific	T	cells
gp130
Figure 7
E
lck cre p25Tg stat3fl/fl lck cre p25Tg
lck cre p25Tg socs3fl/fl lck cre p25Tg
 46 
PAPER III. CISH IN THE CONTROL OF M. TUBERCULOSIS INFECTION 
 
The “cytokine-inducible SRC homology 2 (SH2) domain protein” CISH is one of SOCS 
family members. Single nucleotide polymorphisms (SNPs) in CISH gene were associated 
with increased risk of TB [181-184]. We investigated the role of CISH in the outcome of M. 
tuberculosis infection using a CISH knockout mouse model. 
First, we compared the bacteria burden in lungs and spleen from WT and cish
-/- 
mice at 
different time points after M. tuberculosis infection. Cish
-/- 
mice displayed increased bacterial 
load in lungs at 1.5 and 2.5 weeks. In spleens, cish
-/-
 mice contained higher bacterial loads at 
2.5 weeks (bacterial load was under detection levels in the spleen at earlier time points) 
compared with WT controls. Instead, the bacteria load in lungs and spleens of WT and cish
-/- 
mice at 4 and 8 weeks after infection were comparable. According to the susceptibility of WT 
and cish
-/-
 mice with M. tuberculosis infection, we suggested that CISH regulated innate 
immune mechanisms of M. tuberculosis control.  
In line with this, T cells from cish-/- mice stimulated with CD3/CD28 expressed comparable 
levels of IFN-γ as WT T cells. Moreover, rag1-/- mice adoptively transferred with WT or 
cish-/- T cells and infected with M. tuberculosis showed similar bacteria load, indicating 
that CISH is required for innate immune responses but is redundant for T cell mediated 
protection against M. tuberculosis infection. 
TNF-α, NO/iNOS, IL-6 and IL-1 can be induced in an innate manner and are relevant for M. 
tuberculosis infection control [321-323]. We found reduced transcript levels of tnf and inos 
(but not il-6 and il1b) in lungs of cish
-/- 
mice early, but not at late time points after infection. 
Thus CISH could positively regulate TNF-α and iNOS expression early after infection. In the 
contrary, CISH was redundant in regulation of il6 or il1b mRNA levels in lungs. 
We performed M. tuberculosis infections of BMM in vitro in macrophages and found that 
cish mRNA was increased after infection. However, we neither observed the reduction of tnf 
or inos mRNA levels observed inn vivo (despite these are stimulated by the infection in 
vitro), not a difference in the bacterial load of BMM.   
During the writing of this thesis another manuscript addressing the role of CISH during 
infection with M. tuberculosis in mice has been published[324]. In this manuscript, contrary 
to ours, mice lacking CISH were more resistant to infection with M. tuberculosis and this 
phenomenon, which is observed at 3 and 6 weeks after infection, was linked to the binding of 
CISH to inhibit proton pump in macrophages. In this model CISH function seems not to be 
related to inhibition of JAK/ STAT pathway.  
Neutrophils are the first wave of host defense to infection and have been shown to be 
involved in mediating protective immune responses during the early stage of M. tuberculosis 
infection [233, 325]. However, similar neutrophil frequencies were found in lungs from 
control and cish
-/-
 mice excluding a role for CISH in neutrophil recruitment. 
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In summary, and despite the precise molecular mechanisms need to be examined in further 
detail, the CISH mediates control of M. tuberculosis in mice early infection via regulation of 
innate immune mechanisms.  
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PAPER IV. OFF TARGETS EFFECTS OF LCK CRE IN T CELL DEVELOPMENT 
 
We have used extensively used in our studies gene conditional knockdown system mediated 
by DNA recombinase Cre (cre that recognizes a loxP sequence, both enzyme and target 
sequence derived from a bacteriophage). If cells that contain loxP sites in their genome 
express Cre, a recombination event can occur between these sites. The Cre recombination can 
be used to create deletions, insertions, translocations or inversions at certain sites in the 
genome. Many genes have been targeted in this manner and their function in different cell 
types, tissues and organs in the organism under specific promoters can be studied [326].  
Despite this tool care must be considered when analyzing the effect of cre under the control 
of strong promoters since off targets effects of cre in the specific populations have been 
reported. Cre probably mediated gene recombination by binding to pseudo-loxP sites. For 
example, mice with the Cre expression controlled by insulin promoter displayed the insulin 
resistant regardless of any loxP-targeted gene[327].  
The tyrosine kinase p56 termed Lck is critical for T lymphocyte development and 
function[328-330]. Many different kinds of transgenic mice generated by the Cre system 
controlled by lck promoter have been described as an important model to study the signaling 
pathways and molecular mechanisms in T cell development or function. Since we have been 
previously used lck cre transgene[131]. However, whether the Cre mediated toxicity for T 
cell development and function under lck promoter has not been well described in depth yet. 
Still, several previous studies have stated that Cre expression controlled by lck promoter 
might intervene with normal T cell development, such as the changes of the frequency of 
different stage of DN cells and the ratio of CD4/CD8 SP cells [331-336]. 
For this purpose, we bred a C57BL/6 mouse strain with Cre recombinase expression 
controlled by lck promoter (lck-cre
+
). We found that the thymic cellularity from lck-cre
+ 
mice 
was reduced by 65%, which is contributed by reduced numbers of DP, CD4 SP and CD8 SP 
cells but not DN cells. Several studies have described the expression of Lck in different 
stages of T cell development in thymus by using the GFP transgenic mouse model. Lck is 
detected in all T cell development stages, especially in DP and CD4 and CD8 SP cells[337, 
338]. Probably, the loss of DP, CD4 and CD8 SP cells in lck-cre
+
 mice was generated by the 
DNA-damage induced apoptosis. As expected, lck cre
+
 DP cells displayed higher frequency 
of Annexin V, a maker of apoptosis compared to controls.   
The αβ and γδ T cell lineage commitment occurs in DN 2 and 3 stages during the b-
selection[339]. We found that the number of γδ TCR positive cell population was higher 
in thymus, spleen and Lymph nodes in lck-cre+ mice than that in control group. A study by 
Saint-Ruf et al. reported that the expression level of Lck in γδ T cell lineage is lower than 
that in αβ T cell lineage[340]. IL-7 produced by thymic epithelial cells is involved in 
many biological events during T cell development including proliferation, 
differentiation and survival. IL-7Rαhigh DN2 cells are biased to be γδ T cell lineage[26]. 
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Coincidentally, increased frequency of IL-7R+ total thymocytes and γδ TCR+ cells within 
DN cells was found in in lck-cre+ mice.  
All the results shown above indicated that Cre expression under the control of lck promoter 
altered the T cell development in thymus. On the other hand, we did a meta analysis of the 
literature and found that studies using Cre under lck promoter are biased depending in the 
control used. So care must be taken consideration to choose the correct control group (in this 
case a cre+ control) when cre induced toxicity is obvious or even better, to avoid the use of 
strong promoters for cre-mediated genetic changes.  
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 PAPER V. DENDRITIC CELLS MIGRATION TO DRAINING LYMPH NODE 
AFTER BCG SKIN INFECTION 
 
Since first used in human in 1921, Bacille Calmette-Guérin (BCG) is the only vaccine against 
M. tuberculosis[341]. The interaction between the antigen presenting cells and lymphocytes 
within draining lymph node (dLN) is the critical step to initiate the adaptive immune response 
and create the immune memory.  
This study focused on DCs migration and CD4 T cell priming after BCG skin infection. In 
order to study the DC migration, 2 hours after BCG inoculation in the footpad, we injected 
Carboxyfluorescein succinimidyl ester (CFSE) to label all the skin cells. Thus we could 
define that DCs by using cell markers by flow cytometry in the draining lymph node. All skin 
DCs express MHC II and CD11c. Five different kinds of DCs in healthy mouse skin were 
defined by several surface markers including EpCAM (CD326), langerin (CD207), CD11b 
and CD103[342].  
We found that MHC II
+
CD11c
high
EpCAM
low
CD11b
high
 DCs are the main DCs population that 
migrated from skin to the popliteal LN (pLN), which is the primary dLN of the footpad. 
Coincidentally, Bachy and co-authors also identified that the MHC II
high
 CD11c+EpCAM-
CD207- skin DCs subset dominated in HIV specific antigen presentation and inducing CD8 T 
cells priming[343]. In addition, Ochiai et al. reported that CD326
low
CD11b
high
 DC was highly 
responsive to BCG and E.coli inoculation[344].  
In summary, the studies shown above together with our findings support the MHC 
II
+
CD11c
high
EpCAM
low
CD11b
high
 skin DCs with the capacity of mobilization from skin to 
dLN after BCG infection. 
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4 SUMMARY 
 
In summary, in this thesis I present we have addressed the role of role of SOCS and STATs 
in T cells development as well as in the outcome of M.tuberculosis infection 
Specifically we found that 
1. SOCS3 is required for T cell development specifically by signaling in TECs. 
  
2. SOCS3 is critical for cortex and medulla formation and organization in thymus 
3. SOCS3 regulates many signaling pathways involved in thymic epithelial cells 
development 
 
STAT3 in M.tuberculosis infection 
1. STAT3 in myeloid cells hampers the bacteria control 
2. STAT3 in myeloid cells inhibits TH17 responses 
3. STAT3 in APCs inhibit the generation of IL-17 secreting mycobacteria-specific T 
cells 
 
CISH in M.tuberculosis infection 
1. CISH is critical for bacteria control in the early time points of M.tuberculosis 
infection 
2. CISH is redundant for the regulation of T cells in M. tuberculosis infection 
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